64 results on '"Leo J. Pallanck"'
Search Results
2. A Drosophila model of mitochondrial disease caused by a complex I mutation that uncouples proton pumping from electron transfer
- Author
-
Jonathon L. Burman, Leslie S. Itsara, Ernst-Bernhard Kayser, Wichit Suthammarak, Adrienne M. Wang, Matt Kaeberlein, Margaret M. Sedensky, Philip G. Morgan, and Leo J. Pallanck
- Subjects
Mitochondria ,Drosophila ,Mitochondrial disease ,Respiratory chain ,Leigh syndrome ,Neurodegeneration ,Medicine ,Pathology ,RB1-214 - Abstract
Mutations affecting mitochondrial complex I, a multi-subunit assembly that couples electron transfer to proton pumping, are the most frequent cause of heritable mitochondrial diseases. However, the mechanisms by which complex I dysfunction results in disease remain unclear. Here, we describe a Drosophila model of complex I deficiency caused by a homoplasmic mutation in the mitochondrial-DNA-encoded NADH dehydrogenase subunit 2 (ND2) gene. We show that ND2 mutants exhibit phenotypes that resemble symptoms of mitochondrial disease, including shortened lifespan, progressive neurodegeneration, diminished neural mitochondrial membrane potential and lower levels of neural ATP. Our biochemical studies of ND2 mutants reveal that complex I is unable to efficiently couple electron transfer to proton pumping. Thus, our study provides evidence that the ND2 subunit participates directly in the proton pumping mechanism of complex I. Together, our findings support the model that diminished respiratory chain activity, and consequent energy deficiency, are responsible for the pathogenesis of complex-I-associated neurodegeneration.
- Published
- 2014
- Full Text
- View/download PDF
3. Nazo, the Drosophila homolog of the NBIA-mutated protein-c19orf12, is required for triglyceride homeostasis.
- Author
-
Perinthottathil Sreejith, Sara Lolo, Kristen R Patten, Maduka Gunasinghe, Neya More, Leo J Pallanck, and Rajnish Bharadwaj
- Subjects
Genetics ,QH426-470 - Abstract
Lipid dyshomeostasis has been implicated in a variety of diseases ranging from obesity to neurodegenerative disorders such as Neurodegeneration with Brain Iron Accumulation (NBIA). Here, we uncover the physiological role of Nazo, the Drosophila melanogaster homolog of the NBIA-mutated protein-c19orf12, whose function has been elusive. Ablation of Drosophila c19orf12 homologs leads to dysregulation of multiple lipid metabolism genes. nazo mutants exhibit markedly reduced gut lipid droplet and whole-body triglyceride contents. Consequently, they are sensitive to starvation and oxidative stress. Nazo is required for maintaining normal levels of Perilipin-2, an inhibitor of the lipase-Brummer. Concurrent knockdown of Brummer or overexpression of Perilipin-2 rescues the nazo phenotype, suggesting that this defect, at least in part, may arise from diminished Perilipin-2 on lipid droplets leading to aberrant Brummer-mediated lipolysis. Our findings potentially provide novel insights into the role of c19orf12 as a possible link between lipid dyshomeostasis and neurodegeneration, particularly in the context of NBIA.
- Published
- 2024
- Full Text
- View/download PDF
4. Glucocerebrosidase reduces the spread of protein aggregation in a Drosophila melanogaster model of neurodegeneration by regulating proteins trafficked by extracellular vesicles.
- Author
-
Kathryn A Jewett, Ruth E Thomas, Chi Q Phan, Bernice Lin, Gillian Milstein, Selina Yu, Lisa F Bettcher, Fausto Carnevale Neto, Danijel Djukovic, Daniel Raftery, Leo J Pallanck, and Marie Y Davis
- Subjects
Genetics ,QH426-470 - Abstract
Abnormal protein aggregation within neurons is a key pathologic feature of Parkinson's disease (PD). The spread of brain protein aggregates is associated with clinical disease progression, but how this occurs remains unclear. Mutations in glucosidase, beta acid 1 (GBA), which encodes glucocerebrosidase (GCase), are the most penetrant common genetic risk factor for PD and dementia with Lewy bodies and associate with faster disease progression. To explore how GBA mutations influence pathogenesis, we previously created a Drosophila model of GBA deficiency (Gba1b) that manifests neurodegeneration and accelerated protein aggregation. Proteomic analysis of Gba1b mutants revealed dysregulation of proteins involved in extracellular vesicle (EV) biology, and we found altered protein composition of EVs from Gba1b mutants. Accordingly, we hypothesized that GBA may influence pathogenic protein aggregate spread via EVs. We found that accumulation of ubiquitinated proteins and Ref(2)P, Drosophila homologue of mammalian p62, were reduced in muscle and brain tissue of Gba1b flies by ectopic expression of wildtype GCase in muscle. Neuronal GCase expression also rescued protein aggregation both cell-autonomously in brain and non-cell-autonomously in muscle. Muscle-specific GBA expression reduced the elevated levels of EV-intrinsic proteins and Ref(2)P found in EVs from Gba1b flies. Perturbing EV biogenesis through neutral sphingomyelinase (nSMase), an enzyme important for EV release and ceramide metabolism, enhanced protein aggregation when knocked down in muscle, but did not modify Gba1b mutant protein aggregation when knocked down in neurons. Lipidomic analysis of nSMase knockdown on ceramide and glucosylceramide levels suggested that Gba1b mutant protein aggregation may depend on relative depletion of specific ceramide species often enriched in EVs. Finally, we identified ectopically expressed GCase within isolated EVs. Together, our findings suggest that GCase deficiency promotes accelerated protein aggregate spread between cells and tissues via dysregulated EVs, and EV-mediated trafficking of GCase may partially account for the reduction in aggregate spread.
- Published
- 2021
- Full Text
- View/download PDF
5. Inactivation of the mitochondrial protease Afg3l2 results in severely diminished respiratory chain activity and widespread defects in mitochondrial gene expression.
- Author
-
Gautam Pareek and Leo J Pallanck
- Subjects
Genetics ,QH426-470 - Abstract
The m-AAA proteases play a critical role in the proteostasis of inner mitochondrial membrane proteins, and mutations in the genes encoding these proteases cause severe incurable neurological diseases. To further explore the biological role of the m-AAA proteases and the pathological consequences of their deficiency, we used a genetic approach in the fruit fly Drosophila melanogaster to inactivate the ATPase family gene 3-like 2 (AFG3L2) gene, which encodes a critical component of the m-AAA proteases. We found that null alleles of Drosophila AFG3L2 die early in development, but partial inactivation of AFG3L2 using RNAi allowed survival to the late pupal and adult stages of development. Flies with partial inactivation of AFG3L2 exhibited behavioral defects, neurodegeneration, accumulation of unfolded mitochondrial proteins, and diminished respiratory chain (RC) activity. Further work revealed that the reduced RC activity was primarily a consequence of severely diminished mitochondrial transcription and translation. These defects were accompanied by activation of the mitochondrial unfolded protein response (mito-UPR) and autophagy. Overexpression of mito-UPR components partially rescued the AFG3L2-deficient phenotypes, indicating that protein aggregation partly accounts for the defects of AFG3L2-deficient animals. Our work suggests that strategies designed to activate mitochondrial stress pathways and mitochondrial gene expression could be therapeutic in the diseases caused by mutations in AFG3L2.
- Published
- 2020
- Full Text
- View/download PDF
6. Deleterious mitochondrial DNA point mutations are overrepresented in Drosophila expressing a proofreading-defective DNA polymerase γ.
- Author
-
Colby L Samstag, Jake G Hoekstra, Chiu-Hui Huang, Mark J Chaisson, Richard J Youle, Scott R Kennedy, and Leo J Pallanck
- Subjects
Genetics ,QH426-470 - Abstract
Mitochondrial DNA (mtDNA) mutations cause severe maternally inherited syndromes and the accumulation of somatic mtDNA mutations is implicated in aging and common diseases. However, the mechanisms that influence the frequency and pathogenicity of mtDNA mutations are poorly understood. To address this matter, we created a Drosophila mtDNA mutator strain expressing a proofreading-deficient form of the mitochondrial DNA polymerase. Mutator flies have a dramatically increased somatic mtDNA mutation frequency that correlates with the dosage of the proofreading-deficient polymerase. Mutator flies also exhibit mitochondrial dysfunction, shortened lifespan, a progressive locomotor deficit, and loss of dopaminergic neurons. Surprisingly, the frequency of nonsynonymous, pathogenic, and conserved-site mutations in mutator flies exceeded predictions of a neutral mutational model, indicating the existence of a positive selection mechanism that favors deleterious mtDNA variants. We propose from these findings that deleterious mtDNA mutations are overrepresented because they selectively evade quality control surveillance or because they are amplified through compensatory mitochondrial biogenesis.
- Published
- 2018
- Full Text
- View/download PDF
7. Nazo, the Drosophila homolog of the NBIA-mutated protein – c19orf12, is required for triglyceride homeostasis
- Author
-
Perinthottathil Sreejith, Sara Lolo, Kristen R. Patten, Maduka Gunasinghe, Neya More, Leo J. Pallanck, and Rajnish Bharadwaj
- Abstract
SUMMARYLipid dyshomeostasis has been implicated in a variety of diseases ranging from obesity to neurodegenerative disorders such as NBIA. Here, we uncover the physiological role of Nazo, the Drosophila homolog of the NBIA-mutated protein – c19orf12, whose function has been elusive. Ablation of Drosophila c19orf12 homologs leads to dysregulation of multiple lipid metabolism genes. nazo mutants exhibit markedly reduced gut lipid droplet and whole-body triglyceride contents. Consequently, they are sensitive to starvation and oxidative stress. Nazo localizes to ER-lipid droplet contact sites and is required for maintaining normal levels of Perilipin2, an inhibitor of the lipase – Brummer. Concurrent knockdown of Brummer or overexpression of Perilipin2 rescues the nazo phenotype, suggesting that this defect may arise from diminished Perilipin2 on lipid droplets leading to aberrant Brummer-mediated lipolysis. Our findings provide novel insights into the role of c19orf12 as a possible link between lipid dyshomeostasis and neurodegeneration, particularly in the context of NBIA.
- Published
- 2022
8. Tissue-restricted inhibition of mTOR using chemical genetics
- Author
-
Douglas R. Wassarman, Kondalarao Bankapalli, Leo J. Pallanck, and Kevan M. Shokat
- Subjects
Sirolimus ,Multidisciplinary ,kinase inhibitor ,rapamycin ,1.1 Normal biological development and functioning ,TOR Serine-Threonine Kinases ,Tacrolimus Binding Protein 1A ,tissue specific ,Underpinning research ,Organ Specificity ,mTOR ,Genetics ,Humans ,Drosophila ,Generic health relevance ,Phosphorylation ,Protein Kinase Inhibitors ,Cancer ,Signal Transduction - Abstract
mTOR is a highly conserved eukaryotic protein kinase that coordinates cell growth and metabolism and plays a critical role in cancer, immunity, and aging. It remains unclear how mTOR signaling in individual tissues contributes to whole-organism processes because mTOR inhibitors, like the natural product Rapamycin, are administered systemically and target multiple tissues simultaneously. We developed a chemical-genetic system, termed selecTOR, that restricts the activity of a Rapamycin analog to specific cell populations through targeted expression of a mutant FKBP12 protein. This analog has reduced affinity for its obligate binding partner FKBP12, which reduces its ability to inhibit mTOR in wild-type cells and tissues. Expression of the mutant FKBP12, which contains an expanded binding pocket, rescues the activity of this Rapamycin analog. Using this system, we show that selective mTOR inhibition can be achieved in S. cerevisiae and human cells, and we validate the utility of our system in an intact metazoan model organism by identifying the tissues responsible for a Rapamycin-induced developmental delay in Drosophila.Significance StatementmTOR plays a number of critical organismal roles, including in cell growth, development, immunity and aging, but dissecting the tissue-specific influences of mTOR has proven challenging. This work describes a simple system for identifying the specific tissues and cells responsible for the diverse functions of mTOR, and we show that our system can be used in organisms ranging from yeast to humans.
- Published
- 2022
9. A mitochondrial DNA hypomorph of cytochrome oxidase specifically impairs male fertility in Drosophila melanogaster
- Author
-
Maulik R Patel, Ganesh K Miriyala, Aimee J Littleton, Heiko Yang, Kien Trinh, Janet M Young, Scott R Kennedy, Yukiko M Yamashita, Leo J Pallanck, and Harmit S Malik
- Subjects
mitochondrial DNA ,experimental evolution ,male fertility ,sperm development ,lifespan ,genetic suppressors ,Medicine ,Science ,Biology (General) ,QH301-705.5 - Abstract
Due to their strict maternal inheritance in most animals and plants, mitochondrial genomes are predicted to accumulate mutations that are beneficial or neutral in females but harmful in males. Although a few male-harming mtDNA mutations have been identified, consistent with this ‘Mother’s Curse’, their effect on females has been largely unexplored. Here, we identify COIIG177S, a mtDNA hypomorph of cytochrome oxidase II, which specifically impairs male fertility due to defects in sperm development and function without impairing other male or female functions. COIIG177S represents one of the clearest examples of a ‘male-harming’ mtDNA mutation in animals and suggest that the hypomorphic mtDNA mutations like COIIG177S might specifically impair male gametogenesis. Intriguingly, some D. melanogaster nuclear genetic backgrounds can fully rescue COIIG177S -associated sterility, consistent with previously proposed models that nuclear genomes can regulate the phenotypic manifestation of mtDNA mutations.
- Published
- 2016
- Full Text
- View/download PDF
10. Glucocerebrosidase Deficiency in Drosophila Results in α-Synuclein-Independent Protein Aggregation and Neurodegeneration.
- Author
-
Marie Y Davis, Kien Trinh, Ruth E Thomas, Selina Yu, Alexandre A Germanos, Brittany N Whitley, Sergio Pablo Sardi, Thomas J Montine, and Leo J Pallanck
- Subjects
Genetics ,QH426-470 - Abstract
Mutations in the glucosidase, beta, acid (GBA1) gene cause Gaucher's disease, and are the most common genetic risk factor for Parkinson's disease (PD) and dementia with Lewy bodies (DLB) excluding variants of low penetrance. Because α-synuclein-containing neuronal aggregates are a defining feature of PD and DLB, it is widely believed that mutations in GBA1 act by enhancing α-synuclein toxicity. To explore this hypothesis, we deleted the Drosophila GBA1 homolog, dGBA1b, and compared the phenotypes of dGBA1b mutants in the presence and absence of α-synuclein expression. Homozygous dGBA1b mutants exhibit shortened lifespan, locomotor and memory deficits, neurodegeneration, and dramatically increased accumulation of ubiquitinated protein aggregates that are normally degraded through an autophagic mechanism. Ectopic expression of human α-synuclein in dGBA1b mutants resulted in a mild enhancement of dopaminergic neuron loss and increased α-synuclein aggregation relative to controls. However, α-synuclein expression did not substantially enhance other dGBA1b mutant phenotypes. Our findings indicate that dGBA1b plays an important role in the metabolism of protein aggregates, but that the deleterious consequences of mutations in dGBA1b are largely independent of α-synuclein. Future work with dGBA1b mutants should reveal the mechanism by which mutations in dGBA1b lead to accumulation of protein aggregates, and the potential influence of this protein aggregation on neuronal integrity.
- Published
- 2016
- Full Text
- View/download PDF
11. Genetic models of Parkinson's disease: mechanisms and therapies
- Author
-
Alexander J. Whitworth and Leo J. Pallanck
- Published
- 2020
12. Slowed Protein Turnover in Aging Drosophila Reflects a Shift in Cellular Priorities
- Author
-
Leo J. Pallanck, Gennifer E. Merrihew, Michael J. MacCoss, Evelyn S. Vincow, and Ruth E. Thomas
- Subjects
0301 basic medicine ,Proteomics ,Aging ,THE JOURNAL OF GERONTOLOGY: Biological Sciences ,Protein aggregation ,03 medical and health sciences ,0302 clinical medicine ,Protein biosynthesis ,Animals ,Drosophila Proteins ,biology ,Chemistry ,Protein turnover ,Proteins ,Translation (biology) ,Metabolism ,biology.organism_classification ,Cell biology ,030104 developmental biology ,Proteostasis ,Drosophila melanogaster ,Drosophila ,Geriatrics and Gerontology ,Protein quality ,030217 neurology & neurosurgery - Abstract
The accumulation of protein aggregates and dysfunctional organelles as organisms age has led to the hypothesis that aging involves general breakdown of protein quality control. We tested this hypothesis using a proteomic and informatic approach in the fruit fly Drosophila melanogaster. Turnover of most proteins was markedly slower in old flies. However, ribosomal and proteasomal proteins maintained high turnover rates, suggesting that the observed slowdowns in protein turnover might not be due to a global failure of quality control. As protein turnover reflects the balance of protein synthesis and degradation, we investigated whether decreases in synthesis or decreases in degradation would best explain the observed slowdowns in protein turnover. We found that while many individual proteins in old flies showed slower turnover due to decreased degradation, an approximately equal number showed slower turnover due to decreased synthesis, and enrichment analyses revealed that translation machinery itself was less abundant. Mitochondrial complex I subunits and glycolytic enzymes were decreased in abundance as well, and proteins involved in glutamine-dependent anaplerosis were increased, suggesting that old flies modify energy production to limit oxidative damage. Together, our findings suggest that age-related proteostasis changes in Drosophila represent a coordinated adaptation rather than a system collapse.
- Published
- 2020
13. Glucocerebrosidase reduces the spread of protein aggregation in a Drosophila melanogaster model of neurodegeneration by regulating proteins trafficked by extracellular vesicles
- Author
-
Kathryn A. Jewett, Marie Y. Davis, Ruth E. Thomas, Leo J. Pallanck, Chi Q. Phan, Gillian Milstein, and Selina Yu
- Subjects
Neurodegeneration ,Mutant ,medicine ,Wild type ,Ectopic expression ,Extracellular vesicle ,Biology ,Protein aggregation ,Drosophila melanogaster ,medicine.disease ,biology.organism_classification ,Glucocerebrosidase ,Cell biology - Abstract
Abnormal protein aggregation within neurons is a key pathologic feature of Parkinson’s disease (PD). The spread of protein aggregates in the brain is associated with clinical disease progression, but how this occurs remains unclear. Mutations in the gene glucosidase, beta acid 1 (GBA), which encodes the lysosomal enzyme glucocerebrosidase (GCase), are the most penetrant common genetic risk factor for PD and dementia with Lewy bodies, and also associate with faster disease progression. To explore the mechanism by which mutations in GBA influence pathogenesis of these diseases, we previously created a Drosophila model of GBA deficiency (Gba1b) that manifests neurodegeneration, motor and cognitive deficits, and accelerated protein aggregation. Proteomic analysis of Gba1b mutants revealed dysregulation of proteins involved in extracellular vesicle (EV) biology, and we found altered protein composition of EVs from Gba1b mutants. To further investigate this novel mechanism, we hypothesized that GBA may influence the spread of pathogenic protein aggregates throughout the brain via EVs. We found that protein aggregation is reduced cell-autonomously and non-cell-autonomously by expressing wildtype GCase in specific tissues. In particular, accumulation of insoluble ubiquitinated proteins and Ref(2)P in the brains of Gba1b flies are reduced by ectopic expression of GCase in muscle tissue. Neuronal expression of GCase also cell-autonomously rescued protein aggregation in brain as well as non-cell-autonomously rescued protein aggregation in muscle. Muscle-specific GBA expression rescued the elevated levels of EV-intrinsic proteins and Ref(2)P found in EVs from Gba1b flies. Genetically perturbing EV biogenesis in specific tissues in the absence of GCase revealed differential cell-autonomous effects on protein aggregation but could not replicate the non-cell-autonomous rescue observed with tissue-specific GBA expression. Additionally, we identified ectopically expressed GCase within isolated EVs. Together, our findings suggest that GCase deficiency mediates accelerated spread of protein aggregates between cells and tissues via dysregulated EVs, and EV-mediated trafficking of GCase may partially account for the reduction in aggregate spread.Author’s SummaryParkinson’s disease (PD) is a common neurodegenerative disease characterized by abnormal clumps of proteins (aggregates) within the brain and other tissues which can lead to cellular dysfunction and death. Mutations in the gene GBA, which encodes glucocerebrosidase (GCase), are the strongest genetic risk factor for PD, and are associated with faster disease progression. GCase-deficient mutant flies display features suggestive of PD including increased protein aggregation in brain and muscle. We found that restoring GCase protein in the muscle of mutant flies reduced protein aggregation in muscle and the brain, suggesting a mechanism involving interaction between tissues. Previous work indicated that GBA influences extracellular vesicles (EVs) – small membrane-bound structures released by cells to communicate and/or transport cargo from cell to cell. Here, we found increased aggregated proteins within EVs of mutant flies, which was reduced by restoring GCase in muscle. In addition, we found GCase within the EVs, possibly explaining how GCase in one tissue such as muscle could reduce protein aggregation in a distant tissue like the brain. Our findings suggest that GCase influences proteins within EVs, affecting the spread of protein aggregation. This may be important to understanding PD progression and could uncover new targets to slow neurodegeneration.
- Published
- 2020
14. Glucocerebrosidase reduces the spread of protein aggregation in a Drosophila melanogaster model of neurodegeneration by regulating proteins trafficked by extracellular vesicles
- Author
-
Marie Y. Davis, Leo J. Pallanck, Bernice Lin, Fausto Carnevale Neto, Chi Q. Phan, Ruth E. Thomas, Lisa F. Bettcher, Kathryn A. Jewett, Gillian Milstein, Selina Yu, Danijel Djukovic, and Daniel Raftery
- Subjects
Cancer Research ,Proteome ,Muscle Proteins ,QH426-470 ,Protein aggregation ,Biochemistry ,chemistry.chemical_compound ,0302 clinical medicine ,Medical Conditions ,Mathematical and Statistical Techniques ,Contractile Proteins ,Mutant protein ,Medicine and Health Sciences ,Drosophila Proteins ,Genetics (clinical) ,Neurons ,0303 health sciences ,Principal Component Analysis ,Movement Disorders ,Muscles ,Drosophila Melanogaster ,Neurodegeneration ,Statistics ,Brain ,Eukaryota ,Parkinson Disease ,Neurodegenerative Diseases ,Extracellular vesicle ,Animal Models ,Cell biology ,DNA-Binding Proteins ,Insects ,Neurology ,Experimental Organism Systems ,Gene Knockdown Techniques ,Physical Sciences ,Glucosylceramidase ,RNA Interference ,Drosophila ,Anatomy ,Research Article ,Ceramide ,Arthropoda ,Muscle Tissue ,Biology ,Ceramides ,Glucosylceramides ,Research and Analysis Methods ,Biosynthesis ,Protein Aggregation, Pathological ,03 medical and health sciences ,Extracellular Vesicles ,Model Organisms ,Genetics ,medicine ,Animals ,Statistical Methods ,Molecular Biology ,Ecology, Evolution, Behavior and Systematics ,Actin ,030304 developmental biology ,Organisms ,Biology and Life Sciences ,Proteins ,Biological Transport ,medicine.disease ,Protein Aggregation ,Invertebrates ,Actins ,Disease Models, Animal ,Cytoskeletal Proteins ,Biological Tissue ,chemistry ,Lipidomics ,Mutation ,Multivariate Analysis ,Animal Studies ,Ectopic expression ,Glucocerebrosidase ,Zoology ,Entomology ,030217 neurology & neurosurgery ,Mathematics - Abstract
Abnormal protein aggregation within neurons is a key pathologic feature of Parkinson’s disease (PD). The spread of brain protein aggregates is associated with clinical disease progression, but how this occurs remains unclear. Mutations in glucosidase, beta acid 1 (GBA), which encodes glucocerebrosidase (GCase), are the most penetrant common genetic risk factor for PD and dementia with Lewy bodies and associate with faster disease progression. To explore how GBA mutations influence pathogenesis, we previously created a Drosophila model of GBA deficiency (Gba1b) that manifests neurodegeneration and accelerated protein aggregation. Proteomic analysis of Gba1b mutants revealed dysregulation of proteins involved in extracellular vesicle (EV) biology, and we found altered protein composition of EVs from Gba1b mutants. Accordingly, we hypothesized that GBA may influence pathogenic protein aggregate spread via EVs. We found that accumulation of ubiquitinated proteins and Ref(2)P, Drosophila homologue of mammalian p62, were reduced in muscle and brain tissue of Gba1b flies by ectopic expression of wildtype GCase in muscle. Neuronal GCase expression also rescued protein aggregation both cell-autonomously in brain and non-cell-autonomously in muscle. Muscle-specific GBA expression reduced the elevated levels of EV-intrinsic proteins and Ref(2)P found in EVs from Gba1b flies. Perturbing EV biogenesis through neutral sphingomyelinase (nSMase), an enzyme important for EV release and ceramide metabolism, enhanced protein aggregation when knocked down in muscle, but did not modify Gba1b mutant protein aggregation when knocked down in neurons. Lipidomic analysis of nSMase knockdown on ceramide and glucosylceramide levels suggested that Gba1b mutant protein aggregation may depend on relative depletion of specific ceramide species often enriched in EVs. Finally, we identified ectopically expressed GCase within isolated EVs. Together, our findings suggest that GCase deficiency promotes accelerated protein aggregate spread between cells and tissues via dysregulated EVs, and EV-mediated trafficking of GCase may partially account for the reduction in aggregate spread., Author summary Parkinson’s disease (PD) is a common neurodegenerative disease characterized by abnormal clumps of proteins (aggregates) within the brain and other tissues which can lead to cellular dysfunction and death. Mutations in the gene GBA, which encodes glucocerebrosidase (GCase), are the strongest genetic risk factor for PD, and are associated with faster disease progression. GCase-deficient mutant flies display features suggestive of PD including increased protein aggregation in brain and muscle. We found that restoring GCase protein in the muscle of mutant flies reduced protein aggregation in muscle and the brain, suggesting a mechanism involving interaction between tissues. Previous work indicated that GBA influences extracellular vesicles (EVs)–small membrane-bound structures released by cells to communicate and/or transport cargo from cell to cell. Here, we found increased aggregated proteins within EVs of mutant flies, which was reduced by restoring GCase in muscle. In addition, we found GCase within the EVs, possibly explaining how GCase in one tissue such as muscle could reduce protein aggregation in a distant tissue like the brain. Our findings suggest that GCase influences proteins within EVs, affecting the spread of protein aggregation. This may be important to understanding PD progression and could uncover new targets to slow neurodegeneration.
- Published
- 2020
15. Loss of the Drosophila m-AAA mitochondrial protease paraplegin results in mitochondrial dysfunction, shortened lifespan, and neuronal and muscular degeneration
- Author
-
Leo J. Pallanck, Gautam Pareek, and Ruth E. Thomas
- Subjects
0301 basic medicine ,Cancer Research ,Proteases ,medicine.medical_treatment ,Longevity ,Immunology ,Respiratory chain ,Mitochondrion ,Protein degradation ,Biology ,Article ,Electron Transport ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,medicine ,Animals ,Drosophila Proteins ,lcsh:QH573-671 ,Protease ,Behavior, Animal ,Sequence Homology, Amino Acid ,Paraplegin ,lcsh:Cytology ,Muscles ,Metalloendopeptidases ,Cell Biology ,Phenotype ,Axons ,Mitochondria ,Cell biology ,Drosophila melanogaster ,030104 developmental biology ,Larva ,Mutation ,Nerve Degeneration ,Synapses ,Axoplasmic transport ,ATPases Associated with Diverse Cellular Activities ,030217 neurology & neurosurgery - Abstract
The progressive accumulation of dysfunctional mitochondria is implicated in aging and in common diseases of the elderly. To oppose this occurrence, organisms employ a variety of strategies, including the selective degradation of oxidatively damaged and misfolded mitochondrial proteins. Genetic studies in yeast indicate that the ATPase Associated with diverse cellular Activities (AAA+) family of mitochondrial proteases account for a substantial fraction of this protein degradation, but their metazoan counterparts have been little studied, despite the fact that mutations in the genes encoding these proteases cause a variety of human diseases. To begin to explore the biological roles of the metazoan mitochondrial AAA+ protease family, we have created a CRISPR/Cas9 allele of the Drosophila homolog of SPG7, which encodes an inner membrane-localized AAA+ protease known as paraplegin. Drosophila SPG7 mutants exhibited shortened lifespan, progressive locomotor defects, sensitivity to chemical and environmental stress, and muscular and neuronal degeneration. Ultrastructural examination of photoreceptor neurons indicated that the neurodegenerative phenotype of SPG7 mutants initiates at the synaptic terminal. A variety of mitochondrial defects accompanied the degenerative phenotypes of SPG7 mutants, including altered axonal transport of mitochondria, accumulation of electron-dense material in the matrix of flight muscle mitochondria, reduced activities of respiratory chain complexes I and II, and severely swollen and dysmorphic mitochondria in the synaptic terminals of photoreceptors. Drosophila SPG7 mutants recapitulate key features of human diseases caused by mutations in SPG7, and thus provide a foundation for the identification of Drosophila paraplegin substrates and strategies that could be used to ameliorate the symptoms of these diseases.
- Published
- 2018
16. PINK1/Parkin mitophagy and neurodegeneration—what do we really know in vivo?
- Author
-
Leo J. Pallanck and Alexander J. Whitworth
- Subjects
0301 basic medicine ,Ubiquitin-Protein Ligases ,Mitochondrial Degradation ,PINK1 ,Mitochondrion ,Biology ,Parkin ,03 medical and health sciences ,In vivo ,Mitophagy ,medicine ,Genetics ,Humans ,chemistry.chemical_classification ,Reactive oxygen species ,Neurodegeneration ,Parkinson Disease ,medicine.disease ,nervous system diseases ,Cell biology ,Mitochondria ,030104 developmental biology ,chemistry ,Nerve Degeneration ,Calcium ,Reactive Oxygen Species ,Protein Kinases ,Developmental Biology - Abstract
Mitochondria are essential organelles that provide cellular energy and buffer cytoplasmic calcium. At the same time they produce damaging reactive oxygen species and sequester pro-apoptotic factors. Hence, eukaryotes have evolved exquisite homeostatic processes that maintain mitochondrial integrity, or ultimately remove damaged organelles. This subject has garnered intense interest recently following the discovery that two Parkinson's disease genes, PINK1 and parkin, regulate mitochondrial degradation (mitophagy). The molecular details of PINK1/Parkin-induced mitophagy are emerging but much of our insight derives from work using cultured cells and potent mitochondrial toxins, raising questions about the physiological significance of these findings. Here we review the evidence supporting PINK1/Parkin mitophagy in vivo and its causative role in neurodegeneration, and outline outstanding questions for future investigations.
- Published
- 2017
- Full Text
- View/download PDF
17. Autophagy accounts for approximately one-third of mitochondrial protein turnover and is protein selective
- Author
-
Michael J. MacCoss, Gennifer E. Merrihew, Leo J. Pallanck, Theo K. Bammler, Nicholas J. Shulman, Evelyn S. Vincow, James W. MacDonald, and Ruth E. Thomas
- Subjects
0301 basic medicine ,Proteome ,Ubiquitin-Protein Ligases ,Mitochondrion ,Biology ,Protein degradation ,Proteomics ,Autophagy-Related Protein 7 ,Autophagy-Related Protein 5 ,Mitochondrial Proteins ,03 medical and health sciences ,Mitophagy ,Animals ,Drosophila Proteins ,Humans ,Molecular Biology ,Mitochondrial protein ,030102 biochemistry & molecular biology ,Models, Genetic ,Autophagy ,Protein turnover ,Cell Biology ,Fibroblasts ,Cell biology ,Mitochondria ,030104 developmental biology ,Drosophila melanogaster ,Turnover ,Organ Specificity ,Proteolysis ,Research Paper - Abstract
The destruction of mitochondria through macroautophagy (autophagy) has been recognised as a major route of mitochondrial protein degradation since its discovery more than 50 years ago, but fundamental questions remain unanswered. First, how much mitochondrial protein turnover occurs through auto-phagy? Mitochondrial proteins are also degraded by nonautophagic mechanisms, and the proportion of mitochondrial protein turnover that occurs through autophagy is still unknown. Second, does auto-phagy degrade mitochondrial proteins uniformly or selectively? Autophagy was originally thought to degrade all mitochondrial proteins at the same rate, but recent work suggests that mitochondrial autophagy may be protein selective. To investigate these questions, we used a proteomics-based approach in the fruit fly Drosophila melanogaster, comparing mitochondrial protein turnover rates in autophagy-deficient Atg7 mutants and controls. We found that ~35% of mitochondrial protein turnover occurred via autophagy. Similar analyses using parkin mutants revealed that parkin-dependent mitophagy accounted for ~25% of mitochondrial protein turnover, suggesting that most mitochondrial autophagy specifically eliminates dysfunctional mitochondria. We also found that our results were incompatible with uniform autophagic turnover of mitochondrial proteins and consistent with protein-selective autophagy. In particular, the autophagic turnover rates of individual mitochondrial proteins varied widely, and only a small amount of the variation could be attributed to tissue differences in mitochondrial composition and autophagy rate. Furthermore, analyses comparing autophagy-deficient and control human fibroblasts revealed diverse autophagy-dependent turnover rates even in homogeneous cells. In summary, our work indicates that autophagy acts selectively on mitochondrial proteins, and that most mitochondrial protein turnover occurs through non-autophagic processes. Abbreviations: Atg5: Autophagy-related 5 (Drosophila); ATG5: autophagy related 5 (human); Atg7: Autophagy-related 7 (Drosophila); ATG7: autophagy related 7 (human); DNA: deoxyribonucleic acid; ER: endoplasmic reticulum; GFP: green fluorescent protein; MS: mass spectrometry; park: parkin (Drosophila); Pink1: PTEN-induced putative kinase 1 (Drosophila); PINK1: PTEN-induced kinase 1 (human); PRKN: parkin RBR E3 ubiquitin protein ligase (human); RNA: ribonucleic acid; SD: standard deviation; Ub: ubiquitin/ubiquitinated; WT: wild-type; YME1L: YME1 like ATPase (Drosophila); YME1L1: YME1 like 1 ATPase (human)
- Published
- 2019
18. Inactivation of Lon protease reveals a link between mitochondrial unfolded protein stress and mitochondrial translation inhibition
- Author
-
Gautam Pareek and Leo J. Pallanck
- Subjects
0301 basic medicine ,Cancer Research ,Proteases ,Protein Folding ,Protease La ,Mitochondrial translation ,Immunology ,Translational Inhibition ,Mitochondrial Proteins ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,Mitochondrial unfolded protein response ,Animals ,lcsh:QH573-671 ,Caenorhabditis elegans ,030102 biochemistry & molecular biology ,lcsh:Cytology ,Chemistry ,Comment ,Cell Biology ,Cell biology ,Mitochondria ,030104 developmental biology ,Drosophila melanogaster ,Lon Protease ,Unfolded protein response ,Proteostasis ,Unfolded Protein Response ,ATPases Associated with Diverse Cellular Activities ,Protein folding ,Mitochondrial ATPase - Abstract
The mitochondrial Unfolded Protein Response (UPRmt) pathway confers protection from misfolded and aggregated proteins by activating factors that promote protein folding and degradation. Our recent work on Lon protease, a member of the mitochondrial ATPase Associated with diverse cellular Activities (AAA+) family of mitochondrial resident proteases, suggests that mitochondrial translational inhibition may also be a feature of the UPRmt pathway.
- Published
- 2018
19. Lon protease inactivation in Drosophila causes unfolded protein stress and inhibition of mitochondrial translation
- Author
-
Leo J. Pallanck, David R. Morris, Gautam Pareek, Evelyn S. Vincow, and Ruth E. Thomas
- Subjects
0301 basic medicine ,Cancer Research ,Proteases ,Mitochondrial translation ,medicine.medical_treatment ,Immunology ,Respiratory chain ,Biology ,lcsh:RC254-282 ,Article ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,RNA interference ,medicine ,lcsh:QH573-671 ,Gene ,Gene knockdown ,Protease ,lcsh:Cytology ,Translation (biology) ,Cell Biology ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Cell biology ,030104 developmental biology ,bacteria ,030217 neurology & neurosurgery - Abstract
Mitochondrial dysfunction is a frequent participant in common diseases and a principal suspect in aging. To combat mitochondrial dysfunction, eukaryotes have evolved a large repertoire of quality control mechanisms. One such mechanism involves the selective degradation of damaged or misfolded mitochondrial proteins by mitochondrial resident proteases, including proteases of the ATPase Associated with diverse cellular Activities (AAA+) family. The importance of the AAA+ family of mitochondrial proteases is exemplified by the fact that mutations that impair their functions cause a variety of human diseases, yet our knowledge of the cellular responses to their inactivation is limited. To address this matter, we created and characterized flies with complete or partial inactivation of the Drosophila matrix-localized AAA+ protease Lon. We found that a Lon null allele confers early larval lethality and that severely reducing Lon expression using RNAi results in shortened lifespan, locomotor impairment, and respiratory defects specific to respiratory chain complexes that contain mitochondrially encoded subunits. The respiratory chain defects of Lon knockdown (LonKD) flies appeared to result from severely reduced translation of mitochondrially encoded genes. This translational defect was not a consequence of reduced mitochondrial transcription, as evidenced by the fact that mitochondrial transcripts were elevated in abundance in LonKD flies. Rather, the translational defect of LonKD flies appeared to be derived from sequestration of mitochondrially encoded transcripts in highly dense ribonucleoparticles. The translational defect of LonKD flies was also accompanied by a substantial increase in unfolded mitochondrial proteins. Together, our findings suggest that the accumulation of unfolded mitochondrial proteins triggers a stress response that culminates in the inhibition of mitochondrial translation. Our work provides a foundation to explore the underlying molecular mechanisms.
- Published
- 2018
20. Glucocerebrosidase deficiency promotes protein aggregation through dysregulation of extracellular vesicles
- Author
-
Marie Y. Davis, Gennifer E. Merrihew, Michael J. MacCoss, Leo J. Pallanck, Evelyn S. Vincow, and Ruth E. Thomas
- Subjects
0301 basic medicine ,Male ,Proteomics ,Cancer Research ,Mutant ,Cell Membranes ,Protein aggregation ,medicine.disease_cause ,Autophagy-Related Protein 7 ,Biochemistry ,Parkin ,Animals, Genetically Modified ,Drosophila Proteins ,Genetics (clinical) ,Energy-Producing Organelles ,Mutation ,Cell Death ,Drosophila Melanogaster ,Eukaryota ,Parkinson Disease ,Animal Models ,Cell biology ,Mitochondria ,Insects ,Experimental Organism Systems ,Cell Processes ,Glucosylceramidase ,Drosophila ,Female ,Cellular Structures and Organelles ,Research Article ,lcsh:QH426-470 ,Arthropoda ,Autophagic Cell Death ,Biology ,Bioenergetics ,Research and Analysis Methods ,Protein Aggregation, Pathological ,03 medical and health sciences ,Extracellular Vesicles ,Model Organisms ,Genetics ,medicine ,Autophagy ,Animals ,Humans ,Vesicles ,Microautophagy ,Molecular Biology ,Ecology, Evolution, Behavior and Systematics ,Protein turnover ,Organisms ,Biology and Life Sciences ,Membrane Proteins ,Proteins ,Protein Complexes ,Proteasomes ,Cell Biology ,Invertebrates ,Protein Aggregation ,lcsh:Genetics ,Disease Models, Animal ,030104 developmental biology ,Membrane protein ,Animal Studies ,Lysosomes ,Glucocerebrosidase - Abstract
Mutations in the glucosylceramidase beta (GBA) gene are strongly associated with neurodegenerative diseases marked by protein aggregation. GBA encodes the lysosomal enzyme glucocerebrosidase, which breaks down glucosylceramide. A common explanation for the link between GBA mutations and protein aggregation is that lysosomal accumulation of glucosylceramide causes impaired autophagy. We tested this hypothesis directly by measuring protein turnover and abundance in Drosophila mutants with deletions in the GBA ortholog Gba1b. Proteomic analyses revealed that known autophagy substrates, which had severely impaired turnover in autophagy-deficient Atg7 mutants, showed little to no overall slowing of turnover or increase in abundance in Gba1b mutants. Likewise, Gba1b mutants did not have the marked impairment of mitochondrial protein turnover seen in mitophagy-deficient parkin mutants. Proteasome activity, microautophagy, and endocytic degradation also appeared unaffected in Gba1b mutants. However, we found striking changes in the turnover and abundance of proteins associated with extracellular vesicles (EVs), which have been proposed as vehicles for the spread of protein aggregates in neurodegenerative disease. These changes were specific to Gba1b mutants and did not represent an acceleration of normal aging. Western blotting of isolated EVs confirmed the increased abundance of EV proteins in Gba1b mutants, and nanoparticle tracking analysis revealed that Gba1b mutants had six times as many EVs as controls. Genetic perturbations of EV production in Gba1b mutants suppressed protein aggregation, demonstrating that the increase in EV abundance contributed to the accumulation of protein aggregates. Together, our findings indicate that glucocerebrosidase deficiency causes pathogenic changes in EV metabolism and may promote the spread of protein aggregates through extracellular vesicles., Author summary Mutations in the GBA gene, which encodes the enzyme glucocerebrosidase, are common and increase the risk of Parkinson disease. A widely accepted explanation for the increased risk is that the fatty substance normally broken down by glucocerebrosidase builds up in the lysosome, which is the cell’s recycling center, until the cell can no longer get rid of damaged parts. At that point, proteins that should be destroyed in the lysosome form large clumps (aggregates) throughout the cell. We used mutant fruit flies without glucocerebrosidase to test this theory, and we were surprised to see no evidence that the lysosome was failing. The destruction of proteins usually recycled by the lysosome was not slowed down in the mutant flies. Instead, we saw evidence that the mutants’ cells might be producing too many extracellular vesicles, tiny spheres that transport cargo and messages from cell to cell. Some researchers have also suggested that extracellular vesicles carry the protein aggregates that spread between cells as Parkinson disease get worse. Our study supports this idea. It suggests that increased spread of aggregates through extracellular vesicles, rather than failure of the lysosome, might explain why GBA mutations increase the risk of neurodegenerative disease.
- Published
- 2018
21. A Drosophila model of mitochondrial disease caused by a complex I mutation that uncouples proton pumping from electron transfer
- Author
-
Margaret M. Sedensky, Wichit Suthammarak, Jonathon L. Burman, Leslie S. Itsara, Ernst Bernhard Kayser, Matt Kaeberlein, Adrienne M. Wang, Philip G. Morgan, and Leo J. Pallanck
- Subjects
Mitochondrial Diseases ,Mitochondrial disease ,Protein subunit ,Mutant ,Neuroscience (miscellaneous) ,Respiratory chain ,Medicine (miscellaneous) ,lcsh:Medicine ,Mitochondrion ,medicine.disease_cause ,Oxidative Phosphorylation ,General Biochemistry, Genetics and Molecular Biology ,Electron Transport ,03 medical and health sciences ,0302 clinical medicine ,Immunology and Microbiology (miscellaneous) ,medicine ,lcsh:Pathology ,Animals ,Neurodegeneration ,030304 developmental biology ,0303 health sciences ,Mutation ,Electron Transport Complex I ,biology ,lcsh:R ,NADH dehydrogenase ,Proton Pumps ,medicine.disease ,Leigh syndrome ,Cell biology ,Mitochondria ,Disease Models, Animal ,Biochemistry ,biology.protein ,Drosophila ,Reactive Oxygen Species ,030217 neurology & neurosurgery ,Research Article ,lcsh:RB1-214 - Abstract
Mutations affecting mitochondrial complex I, a multi-subunit assembly that couples electron transfer to proton pumping, are the most frequent cause of heritable mitochondrial diseases. However, the mechanisms by which complex I dysfunction results in disease remain unclear. Here, we describe a Drosophila model of complex I deficiency caused by a homoplasmic mutation in the mitochondrial-encoded NADH dehydrogenase subunit 2 (ND2) gene. We show that ND2 mutants exhibit phenotypes that resemble symptoms of mitochondrial disease, including shortened lifespan, progressive neurodegeneration, diminished neural mitochondrial membrane potential, and lower levels of neural ATP. Our biochemical studies of ND2 mutants reveal that complex I is unable to efficiently couple electron transfer to proton pumping. Thus, our study provides evidence that the ND2 subunit participates directly in the proton pumping mechanism of complex I. Together, our findings support the model that diminished respiratory chain activity, and consequent energy deficiency, are responsible for the pathogenesis of complex I-associated neurodegeneration.
- Published
- 2014
22. Deleterious mitochondrial DNA point mutations are overrepresented in Drosophila expressing a proofreading-defective DNA polymerase γ
- Author
-
Richard J. Youle, Scott R. Kennedy, Jake G. Hoekstra, Colby L. Samstag, Chiu-Hui Huang, Mark Chaisson, and Leo J. Pallanck
- Subjects
0301 basic medicine ,Aging ,Cancer Research ,DNA polymerase ,Gene Identification and Analysis ,Genes, Insect ,QH426-470 ,Mitochondrion ,Biochemistry ,7. Clean energy ,Animals, Genetically Modified ,0302 clinical medicine ,Invertebrate Genomics ,Drosophila Proteins ,Mutation frequency ,Energy-Producing Organelles ,Genetics (clinical) ,Polymerase ,Genetics ,Organelle Biogenesis ,biology ,Drosophila Melanogaster ,Eukaryota ,Animal Models ,Genomics ,Mitochondrial DNA ,DNA Polymerase gamma ,Mitochondria ,Nucleic acids ,Insects ,Deletion Mutation ,Experimental Organism Systems ,Drosophila ,Cellular Structures and Organelles ,Research Article ,DNA Replication ,Substitution Mutation ,Arthropoda ,Forms of DNA ,Longevity ,Motor Activity ,Bioenergetics ,Research and Analysis Methods ,DNA, Mitochondrial ,03 medical and health sciences ,Model Organisms ,Animals ,Point Mutation ,Mutation Detection ,Molecular Biology ,Gene ,Ecology, Evolution, Behavior and Systematics ,Dopaminergic Neurons ,Point mutation ,Organisms ,Biology and Life Sciences ,DNA ,Cell Biology ,Invertebrates ,030104 developmental biology ,Mitochondrial biogenesis ,Animal Genomics ,Mutation ,Animal Studies ,biology.protein ,030217 neurology & neurosurgery - Abstract
Mitochondrial DNA (mtDNA) mutations cause severe maternally inherited syndromes and the accumulation of somatic mtDNA mutations is implicated in aging and common diseases. However, the mechanisms that influence the frequency and pathogenicity of mtDNA mutations are poorly understood. To address this matter, we created a Drosophila mtDNA mutator strain expressing a proofreading-deficient form of the mitochondrial DNA polymerase. Mutator flies have a dramatically increased somatic mtDNA mutation frequency that correlates with the dosage of the proofreading-deficient polymerase. Mutator flies also exhibit mitochondrial dysfunction, shortened lifespan, a progressive locomotor deficit, and loss of dopaminergic neurons. Surprisingly, the frequency of nonsynonymous, pathogenic, and conserved-site mutations in mutator flies exceeded predictions of a neutral mutational model, indicating the existence of a positive selection mechanism that favors deleterious mtDNA variants. We propose from these findings that deleterious mtDNA mutations are overrepresented because they selectively evade quality control surveillance or because they are amplified through compensatory mitochondrial biogenesis., Author summary The energy needs of an animal cell are supplied by tiny organelles known as mitochondria. Each of the many mitochondria in a cell has a set of blueprints for making more mitochondria, known as mitochondrial DNA (mtDNA). As animals age, their mtDNA acquires irreversible defects called mutations, which accumulate and may cause aging. Cells can selectively destroy malfunctioning mitochondria, so we hypothesized that mitochondria with harmful mutations would be selectively destroyed. To test our theory, we created a fruit fly strain with a high mtDNA mutation rate. Our hypothesis predicts that, because mitochondria bearing harmful mtDNA mutations would be destroyed, we should detect primarily less harmful mutations in our strain. However, the mtDNA mutations we detected were more harmful than expected by chance. We suggest two possible explanations: First, mitochondria with harmful mtDNA mutations may be degraded less often because they generate little energy and are not damaged by toxic byproducts of energy production. Second, cells may compensate for harmful mtDNA mutations by stimulating mitochondria to multiply, creating more healthy mitochondria but also more mitochondria with harmful mtDNA mutations. Future studies will distinguish between these models and further advance our understanding of aging and aging related disease.
- Published
- 2018
23. A mitochondrial DNA hypomorph of cytochrome oxidase specifically impairs male fertility in Drosophila melanogaster
- Author
-
Scott R. Kennedy, Heiko Yang, Ganesh K Miriyala, Janet M. Young, Aimee J Littleton, Leo J. Pallanck, Kien Trinh, Yukiko M. Yamashita, Harmit S. Malik, and Maulik R. Patel
- Subjects
Male ,0301 basic medicine ,Mitochondrial DNA ,QH301-705.5 ,Science ,Mutation, Missense ,mitochondrial DNA ,Mitochondrion ,medicine.disease_cause ,DNA, Mitochondrial ,Genome ,male fertility ,General Biochemistry, Genetics and Molecular Biology ,Electron Transport Complex IV ,Mitochondrial Proteins ,03 medical and health sciences ,medicine ,Animals ,Cytochrome c oxidase ,experimental evolution ,Biology (General) ,Gene ,genetic suppressors ,Genetics ,Mutation ,Experimental evolution ,D. melanogaster ,General Immunology and Microbiology ,biology ,General Neuroscience ,Cell Biology ,General Medicine ,biology.organism_classification ,sperm development ,Drosophila melanogaster ,030104 developmental biology ,Genomics and Evolutionary Biology ,Infertility ,biology.protein ,Medicine ,lifespan ,Research Article - Abstract
Due to their strict maternal inheritance in most animals and plants, mitochondrial genomes are predicted to accumulate mutations that are beneficial or neutral in females but harmful in males. Although a few male-harming mtDNA mutations have been identified, consistent with this ‘Mother’s Curse’, their effect on females has been largely unexplored. Here, we identify COIIG177S, a mtDNA hypomorph of cytochrome oxidase II, which specifically impairs male fertility due to defects in sperm development and function without impairing other male or female functions. COIIG177S represents one of the clearest examples of a ‘male-harming’ mtDNA mutation in animals and suggest that the hypomorphic mtDNA mutations like COIIG177S might specifically impair male gametogenesis. Intriguingly, some D. melanogaster nuclear genetic backgrounds can fully rescue COIIG177S -associated sterility, consistent with previously proposed models that nuclear genomes can regulate the phenotypic manifestation of mtDNA mutations. DOI: http://dx.doi.org/10.7554/eLife.16923.001, eLife digest Cell compartments called mitochondria are responsible for producing much of the energy that animal and plant cells need. Most of the proteins in mitochondria are produced from genes found in another compartment called the nucleus. However, some mitochondrial proteins are made from genes found in the mitochondria themselves. Unlike the genes in the nucleus, which animals and plants inherit from both their mother and father, the mitochondrial “genome” is only passed on along the female line. Therefore, males represent an evolutionary dead-end for mitochondrial genes. Evolutionary theory predicts that this should result in the evolution and spread of mutations that can be harmful to males, providing they do not reduce the ability of females to survive and reproduce. Although such ‘male-harming’ mutations have been well studied in plants, it is less clear how common they are in animals. Patel, Miriyala, Littleton et al. used fruit flies as a model system to identify and characterize male-harming mutations in the mitochondrial genome. The experiments isolated a mitochondrial genome with a single mutation in a gene that encodes an enzyme called cytochrome oxidase II. The mutation is said to be “hypomorphic” because it lowers the activity of the gene. The fertility of male flies with this mutation rapidly declined as they aged. However, the mutation did not appear to lower the fertility of female flies. In fact, apart from the lower male fertility, the mitochondrial mutation did not seem to affect any other traits in males or females. Further experiments revealed that this hypomorphic mutation specifically impairs the development of sperm. Patel, Miriyala, Littleton et al. also found that the effect of the mutation on the fertility of the males depended on the genes in the nucleus of their cells, as some nuclear genomes were able to partially or completely suppress the mutation. This supports previous findings that the effect of mitochondrial mutations in animals and plants may be complex and can be strongly influenced by the genes in their nucleus. Patel, Miriyala, Littleton et al.’s findings suggest that sperm development is particularly susceptible to defects in mitochondria, and that hypomorphic mutations may represent a broader category of ‘male-harming’ mutations in animals. A future challenge will be to find out whether such mutations occur in humans and whether they are associated with infertility in men. DOI: http://dx.doi.org/10.7554/eLife.16923.002
- Published
- 2016
24. Author response: A mitochondrial DNA hypomorph of cytochrome oxidase specifically impairs male fertility in Drosophila melanogaster
- Author
-
Maulik R. Patel, Leo J. Pallanck, Kien Trinh, Heiko Yang, Yukiko M. Yamashita, Ganesh K Miriyala, Janet M. Young, Scott R. Kennedy, Aimee J Littleton, and Harmit S. Malik
- Subjects
0301 basic medicine ,03 medical and health sciences ,Mitochondrial DNA ,030104 developmental biology ,biology ,Male fertility ,biology.protein ,Cytochrome c oxidase ,Drosophila melanogaster ,biology.organism_classification ,Cell biology - Published
- 2016
25. Glucocerebrosidase Deficiency in Drosophila Results in α-Synuclein-Independent Protein Aggregation and Neurodegeneration
- Author
-
Brittany N. Whitley, Sergio Pablo Sardi, Kien Trinh, Marie Y. Davis, Leo J. Pallanck, Selina Yu, Alexandre A. Germanos, Thomas J. Montine, and Ruth E. Thomas
- Subjects
0301 basic medicine ,Cancer Research ,Heredity ,Mutant ,Protein aggregation ,Toxicology ,Pathology and Laboratory Medicine ,Biochemistry ,chemistry.chemical_compound ,0302 clinical medicine ,Animal Cells ,Medicine and Health Sciences ,Genetics (clinical) ,Genetics ,Neurons ,Movement Disorders ,Drosophila Melanogaster ,Neurodegeneration ,Parkinson Disease ,Neurochemistry ,Neurodegenerative Diseases ,Animal Models ,Phenotype ,Cell biology ,Insects ,Phenotypes ,Genetic Mapping ,Neurology ,alpha-Synuclein ,Glucosylceramidase ,Drosophila ,Drosophila melanogaster ,Cellular Types ,Neurochemicals ,Cellular Structures and Organelles ,Research Article ,Arthropoda ,lcsh:QH426-470 ,Variant Genotypes ,Biology ,Research and Analysis Methods ,Protein Aggregation, Pathological ,03 medical and health sciences ,Model Organisms ,mental disorders ,medicine ,Animals ,Humans ,Molecular Biology ,Ecology, Evolution, Behavior and Systematics ,Alpha-synuclein ,Gaucher Disease ,Toxicity ,Dementia with Lewy bodies ,Dopaminergic Neurons ,Organisms ,Biology and Life Sciences ,Cell Biology ,medicine.disease ,biology.organism_classification ,Invertebrates ,nervous system diseases ,lcsh:Genetics ,030104 developmental biology ,chemistry ,nervous system ,Cellular Neuroscience ,Nerve Degeneration ,Ectopic expression ,Lysosomes ,Dopaminergics ,030217 neurology & neurosurgery ,Neuroscience - Abstract
Mutations in the glucosidase, beta, acid (GBA1) gene cause Gaucher’s disease, and are the most common genetic risk factor for Parkinson’s disease (PD) and dementia with Lewy bodies (DLB) excluding variants of low penetrance. Because α-synuclein-containing neuronal aggregates are a defining feature of PD and DLB, it is widely believed that mutations in GBA1 act by enhancing α-synuclein toxicity. To explore this hypothesis, we deleted the Drosophila GBA1 homolog, dGBA1b, and compared the phenotypes of dGBA1b mutants in the presence and absence of α-synuclein expression. Homozygous dGBA1b mutants exhibit shortened lifespan, locomotor and memory deficits, neurodegeneration, and dramatically increased accumulation of ubiquitinated protein aggregates that are normally degraded through an autophagic mechanism. Ectopic expression of human α-synuclein in dGBA1b mutants resulted in a mild enhancement of dopaminergic neuron loss and increased α-synuclein aggregation relative to controls. However, α-synuclein expression did not substantially enhance other dGBA1b mutant phenotypes. Our findings indicate that dGBA1b plays an important role in the metabolism of protein aggregates, but that the deleterious consequences of mutations in dGBA1b are largely independent of α-synuclein. Future work with dGBA1b mutants should reveal the mechanism by which mutations in dGBA1b lead to accumulation of protein aggregates, and the potential influence of this protein aggregation on neuronal integrity., Author Summary Mutations in the glucosidase, beta, acid (GBA1) gene cause Gaucher’s disease (GD), a lysosomal storage disease that includes neurodegenerative phenotypes. Recently, mutations in GBA1 were identified as the strongest genetic risk factor for Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), which are neurodegenerative conditions characterized by intraneuronal protein aggregates containing α-synuclein. To explore how GBA1 mutations lead to neurodegeneration in GD, PD and DLB, we developed a novel invertebrate model of GBA1 insufficiency by deleting the Drosophila GBA1 homolog, dGBA1b. We found that dGBA1b mutants have multiple phenotypes consistent with neuronal dysfunction as seen in PD, DLB and GD, and dramatically increased protein aggregation that is normally cleared through an autophagic mechanism. dGBA1b mutants expressing human α-synuclein in dopaminergic neurons led to dopaminergic neuron loss and α-synuclein aggregation. However, α-synuclein expression had minimal effect on dGBA1b mutant phenotypes, suggesting that the deleterious consequences of glucocerebrosidase deficiency are independent of α-synuclein. These findings significantly contribute to our understanding of the role of GBA1 mutations in the pathogenesis of PD, DLB, and GD, and further studies using this model should elucidate mechanisms underlying these diseases.
- Published
- 2016
26. Induction of the Phase II Detoxification Pathway Suppresses Neuron Loss inDrosophilaModels of Parkinson's Disease
- Author
-
Leo J. Pallanck, Paul D. Wes, Laurie A. Andrews, Katherine F. Moore, Paul J. Muchowski, Joyoti Dey, and Kien Trinh
- Subjects
Parkinson's disease ,Tyrosine 3-Monooxygenase ,Nerve Tissue Proteins ,Biology ,medicine.disease_cause ,Parkin ,Animals, Genetically Modified ,chemistry.chemical_compound ,Isothiocyanates ,medicine ,Animals ,Drosophila Proteins ,Disulfides ,Neurons ,Cell Death ,Dose-Response Relationship, Drug ,General Neuroscience ,Age Factors ,Parkinson Disease ,Articles ,Glutathione ,medicine.disease ,Metabolic Detoxication, Phase II ,nervous system diseases ,Cell biology ,Allyl Compounds ,Disease Models, Animal ,Glutathione S-transferase ,nervous system ,Biochemistry ,chemistry ,Sulfoxides ,Mutation ,Nerve Degeneration ,Phase II Detoxification ,Toxicity ,alpha-Synuclein ,biology.protein ,Synuclein ,Drosophila ,Metabolic Networks and Pathways ,Thiocyanates ,Oxidative stress - Abstract
α-Synuclein aggregates are a common feature of sporadic Parkinson's disease (PD), and mutations that increase α-synuclein abundance confer rare heritable forms of PD. Although these findings suggest that α-synuclein plays a central role in the pathogenesis of this disorder, little is known of the mechanism by which α-synuclein promotes neuron loss or the factors that regulate α-synuclein toxicity. To address these matters, we tested candidate modifiers of α-synuclein toxicity using aDrosophilamodel of PD. In the current work, we focused on phase II detoxification enzymes involved in glutathione metabolism. We find that the neuronal death accompanying α-synuclein expression inDrosophilais enhanced by loss-of-function mutations in genes that promote glutathione synthesis and glutathione conjugation. This neuronal loss can be overcome by genetic or pharmacological interventions that increase glutathione synthesis or glutathione conjugation activity. Moreover, these same pharmacological agents suppress neuron loss inDrosophila parkinmutants, a loss-of-function model of PD. Our results suggest that oxidative stress is a feature of α-synuclein toxicity and that induction of the phase II detoxification pathway represents a potential preventative therapy for PD.
- Published
- 2008
27. Drosophila NPC1b Promotes an Early Step in Sterol Absorption from the Midgut Epithelium
- Author
-
Leo J. Pallanck, Stephen P. Voght, Megan L. Fluegel, and Laurie A. Andrews
- Subjects
Physiology ,Mutant ,HUMDISEASE ,Biology ,Intestinal absorption ,Epithelium ,03 medical and health sciences ,0302 clinical medicine ,Niemann-Pick C1 Protein ,medicine ,polycyclic compounds ,Animals ,Drosophila Proteins ,Molecular Biology ,030304 developmental biology ,0303 health sciences ,Gene Expression Regulation, Developmental ,Membrane Proteins ,Midgut ,Cell Biology ,Sterol ,Sterol regulatory element-binding protein ,Diet ,Sterols ,medicine.anatomical_structure ,Drosophila melanogaster ,Biochemistry ,Organ Specificity ,Gene Targeting ,lipids (amino acids, peptides, and proteins) ,NPC1 ,Digestive System ,030217 neurology & neurosurgery ,Intracellular - Abstract
Summary The NPC1 family of proteins plays crucial roles in the intestinal absorption and intracellular trafficking of sterols. The Drosophila genome encodes two NPC1 homologs, one of which, NPC1a, is required for intracellular sterol trafficking in many tissues. Here we show that the other Drosophila NPC1 family member, NPC1b, is expressed in the midgut epithelium and that NPC1b is essential for growth during the early larval stages of development. NPC1b mutants are severely defective in sterol absorption, and the midgut epithelium of NPC1b mutants is deficient in sterols and sterol trafficking intermediates. By contrast, NPC1a mutants absorb sterols more efficiently than wild-type animals, and, unexpectedly, NPC1b;NPC1a double mutants absorb sterols as efficiently as wild-type animals. Together, these findings suggest that NPC1b plays an early role in sterol absorption, although sterol absorption continues at high efficiency through an NPC1a - and NPC1b -independent mechanism under conditions of impaired intracellular sterol trafficking.
- Published
- 2007
- Full Text
- View/download PDF
28. Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis
- Author
-
Tracey J. Parker, Leo J. Pallanck, Laurie A. Andrews, Jessica C. Greene, and Alexander J. Whitworth
- Subjects
Ubiquitin-Protein Ligases ,Mutant ,medicine.disease_cause ,Parkin ,Parkinsonian Disorders ,Drosophilidae ,Genetics ,medicine ,Animals ,Humans ,Molecular Biology ,Genetics (clinical) ,Mutation ,biology ,General Medicine ,biology.organism_classification ,Phenotype ,Immunity, Innate ,nervous system diseases ,Oxidative Stress ,Drosophila melanogaster ,Unfolded protein response ,Genetic screen - Abstract
Loss-of-function mutations of the parkin gene, which encodes a ubiquitin-protein ligase, are a common cause of autosomal recessive juvenile parkinsonism (ARJP). Previous work has led to the identification of a number of Parkin substrates that implicate specific pathways in ARJP pathogenesis, including endoplasmic reticulum (ER) stress and cell cycle activation. To test the involvement of previously implicated pathways, as well as to identify novel pathways in ARJP pathogenesis, we are using genetic and genomic approaches to study Parkin function in the fruit fly Drosophila melanogaster. In previous work, we demonstrated that Drosophila parkin null mutants exhibit mitochondrial pathology and flight muscle degeneration. To further explore the mechanisms responsible for pathology in parkin mutants, we analyzed the transcriptional alterations that occur during muscle degeneration and performed a genetic screen for parkin modifiers. Results of these studies indicate that oxidative stress response components are induced in parkin mutants and that loss-of-function mutations in oxidative stress components enhance the parkin mutant phenotypes. Genes involved in the innate immune response are also induced in parkin mutants. In contrast, our studies did not reveal evidence for cell cycle or ER stress pathway induction in parkin mutants. These results suggest that oxidative stress and/or inflammation may play a fundamental role in the etiology of ARJP.
- Published
- 2005
29. A SCA7 CAG/CTG repeat expansion is stable in Drosophila melanogaster despite modulation of genomic context and gene dosage
- Author
-
Alexander J. Whitworth, Stephen M. Jackson, Randell T. Libby, Jessica C. Greene, Leo J. Pallanck, Sandy L. Baccam, and Albert R. La Spada
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities ,Candidate gene ,Flap Endonucleases ,Quantitative Trait Loci ,Gene Dosage ,Nerve Tissue Proteins ,Context (language use) ,Biology ,Gene dosage ,Genomic Instability ,Animals, Genetically Modified ,Proliferating Cell Nuclear Antigen ,Genetics ,medicine ,Animals ,Drosophila Proteins ,Gene ,Spinocerebellar Degenerations ,Ataxin-7 ,Genome ,DNA ,General Medicine ,medicine.disease ,biology.organism_classification ,Disease Models, Animal ,DNA Repair Enzymes ,Drosophila melanogaster ,Dynamic mutation ,Spinocerebellar ataxia ,Trinucleotide Repeat Expansion ,Trinucleotide repeat expansion - Abstract
CAG and CTG repeat expansions are the cause of at least a dozen inherited neurological disorders. In these so-called "dynamic mutation" diseases, the expanded repeats display dramatic genetic instability, changing in size when transmitted through the germline and within somatic tissues. As the molecular basis of the repeat instability process remains poorly understood, modeling of repeat instability in model organisms has provided some insights into potentially involved factors, implicating especially replication and repair pathways. Studies in mice have also shown that the genomic context of the repeat sequence is required for CAG/CTG repeat instability in the case of spinocerebellar ataxia type 7 (SCA7), one of the most unstable of all CAG/CTG repeat disease loci. While most studies of repeat instability have taken a candidate gene approach, unbiased screens for factors involved in trinucleotide repeat instability have been lacking. We therefore attempted to use Drosophila melanogaster to model expanded CAG repeat instability by creating transgenic flies carrying trinucleotide repeat expansions, deriving flies with SCA7 CAG90 repeats in cDNA and genomic context. We found that SCA7 CAG90 repeats are stable in Drosophila, regardless of context. To screen for genes whose reduced function might destabilize expanded CAG repeat tracts in Drosophila, we crossed the SCA7 CAG90 repeat flies with various deficiency stocks, including lines lacking genes encoding the orthologues of flap endonuclease-1, PCNA, and MutS. In all cases, perfect repeat stability was preserved, suggesting that Drosophila may not be a suitable system for determining the molecular basis of SCA7 CAG repeat instability.
- Published
- 2005
30. Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease
- Author
-
Nancy M. Bonini, Peter Heutink, Patrizia Rizzu, Alexander J. Whitworth, Paul D. Wes, Leo J. Pallanck, Cecilia E. Armstrong-Gold, Marc C. Meulener, and Biological Psychology
- Subjects
Paraquat ,Parkinson's disease ,Mutant ,Blotting, Western ,Molecular Sequence Data ,Protein Deglycase DJ-1 ,Nerve Tissue Proteins ,Oxidative phosphorylation ,Biology ,medicine.disease_cause ,General Biochemistry, Genetics and Molecular Biology ,Germline ,Animals, Genetically Modified ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Rotenone ,medicine ,Animals ,Cluster Analysis ,Drosophila Proteins ,Amino Acid Sequence ,Gene ,Crosses, Genetic ,Phylogeny ,030304 developmental biology ,Genetics ,Neurons ,0303 health sciences ,Agricultural and Biological Sciences(all) ,Biochemistry, Genetics and Molecular Biology(all) ,Computational Biology ,Parkinson Disease ,medicine.disease ,Survival Analysis ,Oxidative Stress ,chemistry ,Mutation ,Drosophila ,General Agricultural and Biological Sciences ,Sequence Alignment ,030217 neurology & neurosurgery ,Oxidative stress - Abstract
Parkinson's disease (PD) is a common neurodegenerative disorder that displays both sporadic and inherited forms [1]. Exposure to several common environmental toxins acting through oxidative stress has been shown to be associated with PD [2]. One recently identified inherited PD gene, DJ-1, may have a role in protection from oxidative stress [3-10], thus potentially linking a genetic cause with critical environmental risk factors. To develop an animal model that would allow integrative study of genetic and environmental influences, we have generated Drosophila lacking DJ-1 function. Fly DJ-1 homologs exhibit differential expression: DJ-1β is ubiquitous, while DJ-1α is predominantly expressed in the male germline. DJ-1α and DJ-1β double knockout flies are viable, fertile, and have a normal lifespan; however, they display a striking selective sensitivity to those environmental agents, including paraquat and rotenone, linked to PD in humans. This sensitivity results primarily from loss of DJ-1β protein, which also becomes modified upon oxidative stress. These studies demonstrate that fly DJ-1 activity is selectively involved in protection from environmental oxidative insult in vivo and that the DJ-1β protein is biochemically responsive to oxidative stress. Study of these flies will provide insight into the critical interplay of genetics and environment in PD. ©2005 Elsevier Ltd. All rights reserved.
- Published
- 2005
31. Mitophagy: Mitofusin Recruits a Mitochondrial Killer
- Author
-
Leo J. Pallanck
- Subjects
biology ,Agricultural and Biological Sciences(all) ,Biochemistry, Genetics and Molecular Biology(all) ,Ubiquitin-Protein Ligases ,Mitochondrion ,Molecular biology ,Mitochondria, Heart ,Article ,General Biochemistry, Genetics and Molecular Biology ,Parkin ,GTP Phosphohydrolases ,nervous system diseases ,Ubiquitin ligase ,Cytosol ,Mitofusin-2 ,mitochondrial fusion ,Mitophagy ,biology.protein ,Animals ,Humans ,Phosphorylation ,Myocytes, Cardiac ,General Agricultural and Biological Sciences ,Protein Kinases - Abstract
Senescent and damaged mitochondria undergo selective mitophagic elimination through mechanisms requiring two Parkinson’s disease factors, the mitochondrial kinase PINK1 and the cytosolic ubiquitin ligase Parkin. The nature of the PINK-Parkin interaction and identity of key factors directing Parkin to damaged mitochondria are unknown. We show that the mitochondrial outer membrane GTPase mitofusin (Mfn) 2 mediates Parkin recruitment to damaged mitochondria. Parkin bound to Mfn2 in a PINK1-dependent manner; PINK1 phosphorylated Mfn2 and promoted its Parkin-mediated ubiqitination. Ablation of Mfn2 in mouse cardiac myocytes prevented depolarization-induced translocation of Parkin to the mitochondria and suppressed mitophagy. Accumulation of morphologically and functionally abnormal mitochondria induced respiratory dysfunction in Mfn2-deficient mouse embryonic fibroblasts and cardiomyocytes, and in Parkin-deficient Drosophila heart tubes, causing dilated cardiomyopathy. Thus, Mfn2 functions as a mitochondrial receptor for Parkin, and is required for quality control of cardiac mitochondria.
- Published
- 2013
- Full Text
- View/download PDF
32. Genetic Analysis of SolubleN-Ethylmaleimide-Sensitive Factor Attachment Protein Function inDrosophilaReveals Positive and Negative Secretory Roles
- Author
-
Leo J. Pallanck, Jennifer Leither, Greg T. Macleod, and Michael Babcock
- Subjects
Vesicle fusion ,Macromolecular Substances ,DNA Mutational Analysis ,Gene Dosage ,Neuromuscular Junction ,Presynaptic Terminals ,Vesicular Transport Proteins ,Gene Expression ,Genes, Recessive ,Biology ,Membrane Fusion ,Animals, Genetically Modified ,Animals ,Secretion ,Genetic Testing ,N-Ethylmaleimide-Sensitive Proteins ,Alleles ,Secretory pathway ,Neurotransmitter Agents ,SNARE complex disassembly ,integumentary system ,General Neuroscience ,Genetic Complementation Test ,Snap ,Membrane Proteins ,Secretory Vesicle ,Cell biology ,Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins ,Protein Transport ,stomatognathic diseases ,Phenotype ,Larva ,Mutation ,Synapses ,Drosophila ,Genes, Lethal ,Soluble NSF attachment protein ,Carrier Proteins ,SNARE Proteins ,SNARE complex ,Cellular/Molecular - Abstract
TheN-ethylmaleimide-sensitive factor (NSF) and soluble NSF attachment protein (SNAP) are cytosolic factors that promote vesicle fusion with a target membrane in both the constitutive and regulated secretory pathways. NSF and SNAP are thought to function by catalyzing the disassembly of a SNAP receptor (SNARE) complex consisting of membrane proteins of the secretory vesicle and target membrane. Although studies of NSF function have provided strong support for this model, the precise biochemical role of SNAP remains controversial. To further explore the function of SNAP, we have used mutational and transgenic approaches inDrosophilato investigate the effect of altered SNAP dosage on neurotransmitter release and SNARE complex metabolism. Our results indicate that reduced SNAP activity results in diminished neurotransmitter release and accumulation of a neural SNARE complex. Increased SNAP dosage results in defective synapse formation and a variety of tissue morphological defects without detectably altering the abundance of neural SNARE complexes. The SNAP overexpression phenotypes are enhanced by mutations in other secretory components and are at least partially overcome by co-overexpression of NSF, suggesting that these phenotypes derive from a specific perturbation of the secretory pathway. Our results indicate that SNAP promotes neurotransmitter release and SNARE complex disassembly but inhibits secretion when present at high abundance relative to NSF.
- Published
- 2004
33. A Genetic Screen for Synaptic Transmission Mutants Mapping to the Right Arm of Chromosome 3 in Drosophila
- Author
-
Michael Babcock, R. Steven Stowers, Leo J. Pallanck, Jennifer Leither, and Corey S. Goodman
- Subjects
Genetics ,Receptors, Steroid ,CCAAT-Enhancer-Binding Protein-beta ,Mutant ,Chromosome Mapping ,Neurotransmission ,Biology ,Synaptic Transmission ,Synaptic vesicle ,Axons ,DNA-Binding Proteins ,Complementation ,Synapse ,Chromosome 3 ,Animals ,Drosophila ,Gene ,Research Article ,Genetic screen - Abstract
Neuronal function depends upon the proper formation of synaptic connections and rapid communication at these sites, primarily through the regulated exocytosis of chemical neurotransmitters. Recent biochemical and genomic studies have identified a large number of candidate molecules that may function in these processes. To complement these studies, we are pursuing a genetic approach to identify genes affecting synaptic transmission in the Drosophila visual system. Our screening approach involves a recently described genetic method allowing efficient production of mosaic flies whose eyes are entirely homozygous for a mutagenized chromosome arm. From a screen of 42,500 mutagenized flies, 32 mutations on chromosome 3R that confer synaptic transmission defects in the visual system were recovered. These mutations represent 14 complementation groups, of which at least 9 also appear to perform functional roles outside of the eye. Three of these complementation groups disrupt photoreceptor axonal projection, whereas the remaining complementation groups confer presynaptic defects in synaptic transmission without detectably altering photoreceptor structure. Mapping and complementation testing with candidate mutations revealed new alleles of the neuronal fate determinant svp and the synaptic vesicle trafficking component lap among the collection of mutants recovered in this screen. Given the tools available for investigation of synaptic function in Drosophila, these mutants represent a valuable resource for future analysis of synapse development and function.
- Published
- 2003
34. Parkin
- Author
-
Leo J. Pallanck and Mel B. Feany
- Subjects
chemistry.chemical_classification ,DNA ligase ,Neuroscience(all) ,General Neuroscience ,Dopaminergic ,Excitotoxicity ,Disease ,Parkin gene ,Biology ,medicine.disease_cause ,Neuroprotection ,Parkin ,nervous system diseases ,chemistry ,medicine ,Neuroscience - Abstract
An autosomal recessive juvenile-onset form of Parkinson's disease (AR-JP) is caused by loss-of-function mutations of the parkin gene, which encodes a ubiquitin-protein ligase. Three recent reports demonstrate that parkin can protect neurons from diverse cellular insults, including α-synuclein toxicity, proteasomal dysfunction, Pael-R accumulation, and kainate-induced excitotoxicity. These findings suggest a central role for parkin in maintaining dopaminergic neuronal integrity and strengthen the link between AR-JP and the more common sporadic form of Parkinson's disease.
- Published
- 2003
35. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
- Author
-
Mel B. Feany, Jessica C. Greene, Leo J. Pallanck, Isabella Kuo, Laurie A. Andrews, and Alexander J. Whitworth
- Subjects
Male ,Programmed cell death ,Ubiquitin-Protein Ligases ,Longevity ,Molecular Sequence Data ,Apoptosis ,PINK1 ,Substantia nigra ,Mitochondrion ,Biology ,Parkin ,Ligases ,medicine ,Animals ,Amino Acid Sequence ,Cloning, Molecular ,Muscle, Skeletal ,Genetics ,Multidisciplinary ,Sequence Homology, Amino Acid ,Spermatid ,Parkinson Disease ,Biological Sciences ,Spermatids ,Phenotype ,Recombinant Proteins ,Mitochondria ,medicine.anatomical_structure ,Mutagenesis ,Nerve Degeneration ,Drosophila ,Sequence Alignment - Abstract
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by loss of dopaminergic neurons in the substantia nigra. Several lines of evidence strongly implicate mitochondrial dysfunction as a major causative factor in PD, although the molecular mechanisms responsible for mitochondrial dysfunction are poorly understood. Recently, loss-of-function mutations in the parkin gene, which encodes a ubiquitin-protein ligase, were found to underlie a familial form of PD known as autosomal recessive juvenile parkinsonism (AR-JP). To gain insight into the molecular mechanism responsible for selective cell death in AR-JP, we have created a Drosophila model of this disorder. Drosophila parkin null mutants exhibit reduced lifespan, locomotor defects, and male sterility. The locomotor defects derive from apoptotic cell death of muscle subsets, whereas the male sterile phenotype derives from a spermatid individualization defect at a late stage of spermatogenesis. Mitochondrial pathology is the earliest manifestation of muscle degeneration and a prominent characteristic of individualizing spermatids in parkin mutants. These results indicate that the tissue-specific phenotypes observed in Drosophila parkin mutants result from mitochondrial dysfunction and raise the possibility that similar mitochondrial impairment triggers the selective cell loss observed in AR-JP.
- Published
- 2003
36. Ultra-Sensitive Sequencing Reveals an Age-Related Increase in Somatic Mitochondrial Mutations That Are Inconsistent with Oxidative Damage
- Author
-
Scott R. Kennedy, Monica Sanchez-Contreras, Joshua J. Hewitt, Fernando Cardozo-Pelaez, Edward J. Fox, Leslie S. Itsara, Selina Yu, and Leo J. Pallanck
- Subjects
Cancer Research ,Mutation rate ,Mitochondrial DNA ,Aging ,lcsh:QH426-470 ,DNA Repair ,Somatic cell ,DNA repair ,Biology ,medicine.disease_cause ,DNA, Mitochondrial ,DNA Glycosylases ,Germline mutation ,Model Organisms ,Mutation Rate ,Genetic Mutation ,Nucleic Acids ,Molecular Cell Biology ,medicine ,Genetics ,Animals ,Drosophila Proteins ,Humans ,Mutation frequency ,Molecular Biology ,Genetics (clinical) ,Ecology, Evolution, Behavior and Systematics ,Mutation ,Superoxide Dismutase ,Point mutation ,Drosophila Melanogaster ,Animal Models ,DNA ,Molecular biology ,Mitochondria ,lcsh:Genetics ,Oxidative Stress ,Models, Animal ,Reactive Oxygen Species ,Research Article - Abstract
The accumulation of somatic mitochondrial DNA (mtDNA) mutations is implicated in aging and common diseases of the elderly, including cancer and neurodegenerative disease. However, the mechanisms that influence the frequency of somatic mtDNA mutations are poorly understood. To develop a simple invertebrate model system to address this matter, we used the Random Mutation Capture (RMC) assay to characterize the age-dependent frequency and distribution of mtDNA mutations in the fruit fly Drosophila melanogaster. Because oxidative stress is a major suspect in the age-dependent accumulation of somatic mtDNA mutations, we also used the RMC assay to explore the influence of oxidative stress on the somatic mtDNA mutation frequency. We found that many of the features associated with mtDNA mutations in vertebrates are conserved in Drosophila, including a comparable somatic mtDNA mutation frequency (∼10−5), an increased frequency of mtDNA mutations with age, and a prevalence of transition mutations. Only a small fraction of the mtDNA mutations detected in young or old animals were G∶C to T∶A transversions, a signature of oxidative damage, and loss-of-function mutations in the mitochondrial superoxide dismutase, Sod2, had no detectable influence on the somatic mtDNA mutation frequency. Moreover, a loss-of-function mutation in Ogg1, which encodes a DNA repair enzyme that removes oxidatively damaged deoxyguanosine residues (8-hydroxy-2′-deoxyguanosine), did not significantly influence the somatic mtDNA mutation frequency of Sod2 mutants. Together, these findings indicate that oxidative stress is not a major cause of somatic mtDNA mutations. Our data instead suggests that somatic mtDNA mutations arise primarily from errors that occur during mtDNA replication. Further studies using Drosophila should aid in the identification of factors that influence the frequency of somatic mtDNA mutations., Author Summary Mitochondria are the evolutionary remnants of bacteria that were acquired by the cells of our ancestors more than a billion years ago and now produce virtually all of the cellular energy. Due to their bacterial ancestry, mitochondria have their own genomes, which encode some of the machinery responsible for producing energy. These genes occasionally acquire mutations—irreversible alterations that can adversely affect the energy production machinery. The accumulation of mitochondrial DNA (mtDNA) mutations is thought to cause aging and common age-related diseases, but we know little about the factors that influence the frequency of these mutations. Our study tested whether fruit flies would serve as a good animal model to study this problem. We found that flies accumulate mtDNA mutations in a pattern similar to that of humans. We then used flies to test the long-standing theory that toxic free radicals, chemical byproducts of energy production, cause mtDNA mutations to accumulate. Our data do not support this hypothesis, and instead suggest that rare errors associated with duplicating mitochondrial genomes are primarily responsible for mtDNA mutations. In sum we demonstrate that Drosophila serves as a tractable genetic model to investigate the mechanisms that influence the frequency of somatic mtDNA mutations.
- Published
- 2014
37. The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo
- Author
-
Leo J. Pallanck, Michael J. MacCoss, Evelyn S. Vincow, Gennifer E. Merrihew, Richard P. Beyer, Ruth E. Thomas, and Nicholas J. Shulman
- Subjects
Ubiquitin-Protein Ligases ,Mitochondrial Degradation ,Respiratory chain ,PINK1 ,Biology ,Mitochondrion ,Protein Serine-Threonine Kinases ,Autophagy-Related Protein 7 ,Parkin ,Mass Spectrometry ,Electron Transport ,Mitochondrial Proteins ,Mice ,Commentaries ,Mitophagy ,Animals ,Drosophila Proteins ,Multidisciplinary ,Brain ,Parkinson Disease ,Molecular biology ,nervous system diseases ,Cell biology ,Mitochondrial respiratory chain ,Isotope Labeling ,Drosophila ,Half-Life ,Signal Transduction - Abstract
The accumulation of damaged mitochondria has been proposed as a key factor in aging and the pathogenesis of many common age-related diseases, including Parkinson disease (PD). Recently, in vitro studies of the PD-related proteins Parkin and PINK1 have found that these factors act in a common pathway to promote the selective autophagic degradation of damaged mitochondria (mitophagy). However, whether Parkin and PINK1 promote mitophagy under normal physiological conditions in vivo is unknown. To address this question, we used a proteomic approach in Drosophila to compare the rates of mitochondrial protein turnover in parkin mutants, PINK1 mutants, and control flies. We found that parkin null mutants showed a significant overall slowing of mitochondrial protein turnover, similar to but less severe than the slowing seen in autophagy-deficient Atg7 mutants, consistent with the model that Parkin acts upstream of Atg7 to promote mitophagy. By contrast, the turnover of many mitochondrial respiratory chain (RC) subunits showed greater impairment in parkin than Atg7 mutants, and RC turnover was also selectively impaired in PINK1 mutants. Our findings show that the PINK1–Parkin pathway promotes mitophagy in vivo and, unexpectedly, also promotes selective turnover of mitochondrial RC subunits. Failure to degrade damaged RC proteins could account for the RC deficits seen in many PD patients and may play an important role in PD pathogenesis.
- Published
- 2013
38. PINK1-Parkin pathway activity is regulated by degradation of PINK1 in the mitochondrial matrix
- Author
-
Wen-Yang Lin, Leo J. Pallanck, Ruth E. Thomas, Laurie A. Andrews, and Jonathon L. Burman
- Subjects
Cancer Research ,Proteases ,Protease La ,lcsh:QH426-470 ,Ubiquitin-Protein Ligases ,PINK1 ,Biology ,Mitochondrion ,Protein Serine-Threonine Kinases ,Research and Analysis Methods ,Biochemistry ,Parkin ,Model Organisms ,Molecular Cell Biology ,Neurobiology of Disease and Regeneration ,Genetics ,Medicine and Health Sciences ,Animals ,Drosophila Proteins ,Inner mitochondrial membrane ,Molecular Biology ,Genetics (clinical) ,Ecology, Evolution, Behavior and Systematics ,Membrane Potential, Mitochondrial ,Biology and Life Sciences ,Parkinson Disease ,Cell Biology ,Mitochondria ,lcsh:Genetics ,Drosophila melanogaster ,Neurology ,Mitochondrial matrix ,Cellular Neuroscience ,Mutation ,Proteolysis ,Unfolded protein response ,DNAJA3 ,Unfolded Protein Response ,bacteria ,Molecular Neuroscience ,Research Article ,Neuroscience - Abstract
Loss-of-function mutations in PINK1, which encodes a mitochondrially targeted serine/threonine kinase, result in an early-onset heritable form of Parkinson's disease. Previous work has shown that PINK1 is constitutively degraded in healthy cells, but selectively accumulates on the surface of depolarized mitochondria, thereby initiating their autophagic degradation. Although PINK1 is known to be a cleavage target of several mitochondrial proteases, whether these proteases account for the constitutive degradation of PINK1 in healthy mitochondria remains unclear. To explore the mechanism by which PINK1 is degraded, we performed a screen for mitochondrial proteases that influence PINK1 abundance in the fruit fly Drosophila melanogaster. We found that genetic perturbations targeting the matrix-localized protease Lon caused dramatic accumulation of processed PINK1 species in several mitochondrial compartments, including the matrix. Knockdown of Lon did not decrease mitochondrial membrane potential or trigger activation of the mitochondrial unfolded protein stress response (UPRmt), indicating that PINK1 accumulation in Lon-deficient animals is not a secondary consequence of mitochondrial depolarization or the UPRmt. Moreover, the influence of Lon on PINK1 abundance was highly specific, as Lon inactivation had little or no effect on the abundance of other mitochondrial proteins. Further studies indicated that the processed forms of PINK1 that accumulate upon Lon inactivation are capable of activating the PINK1-Parkin pathway in vivo. Our findings thus suggest that Lon plays an essential role in regulating the PINK1-Parkin pathway by promoting the degradation of PINK1 in the matrix of healthy mitochondria., Author Summary Mitochondria are essential organelles that provide most of the cell's energy and perform many other critical functions. The gradual accumulation of defective mitochondria is thought to play a role in aging and in diseases of the nervous system, including Parkinson's disease. The selective elimination of defective mitochondria is therefore a vital task for the cell, and the protein PINK1 was recently identified as a critical player in this process. PINK1 accumulates on the surface of mitochondria after they are damaged, starting a process that leads ultimately to the elimination of defective mitochondria. Previous work indicated that PINK1 does not accumulate on healthy mitochondria because it is rapidly degraded. However, it was unclear exactly how and where this degradation occurred. Our work shows that Lon protease promotes the degradation of PINK1 in the mitochondrial matrix. This finding provides new insight into the mechanisms of mitochondrial quality control, and reveals a potential strategy for treating the many diseases associated with the accumulation of defective mitochondria.
- Published
- 2013
39. Topograph, a Software Platform for Precursor Enrichment Corrected Global Protein Turnover Measurements*
- Author
-
Peter S. Rabinovitch, Nicholas J. Shulman, Edward J. Hsieh, Pabalu P. Karunadharma, Leo J. Pallanck, Michael J. MacCoss, Dao-Fu Dai, and Evelyn S. Vincow
- Subjects
Proteomics ,Proteomics methods ,Molecular Sequence Data ,Mitochondria, Liver ,Biology ,Biochemistry ,Mitochondria, Heart ,Analytical Chemistry ,Mitochondrial Proteins ,Mice ,Software ,Animals ,Amino Acid Sequence ,Amino Acids ,Molecular Biology ,Peptide sequence ,Heart metabolism ,Extramural ,business.industry ,Protein turnover ,Technological Innovation and Resources ,Mice, Inbred C57BL ,Liver metabolism ,Biophysics ,business ,Peptides - Abstract
Defects in protein turnover have been implicated in a broad range of diseases, but current proteomics methods of measuring protein turnover are limited by the software tools available. Conventional methods require indirect approaches to differentiate newly synthesized protein when synthesized from partially labeled precursor pools. To address this, we have developed Topograph, a software platform which calculates the fraction of peptides that are from newly synthesized proteins and their turnover rates. A unique feature of Topograph is the ability to calculate amino acid precursor pool enrichment levels which allows for accurate calculations when the precursor pool is not fully labeled, and the approach used by Topograph is applicable regardless of the stable isotope label used. We validate the Topograph algorithms using data acquired from a mouse labeling experiment and demonstrate the influence that precursor pool corrections can have on protein turnover measurements.
- Published
- 2012
40. Analysis of neural subtypes reveals selective mitochondrial dysfunction in dopaminergic neurons from parkin mutants
- Author
-
Richard B. Decal, Leo J. Pallanck, Selina Yu, Angela C. Poole, and Jonathon L. Burman
- Subjects
Neurons ,Cell type ,Multidisciplinary ,Dopamine ,Ubiquitin-Protein Ligases ,Autophagy ,Dopaminergic ,PINK1 ,Mitochondrion ,Biology ,Biological Sciences ,Parkin ,nervous system diseases ,Membrane Potentials ,Mitochondria ,Mutation ,medicine ,Animals ,Drosophila Proteins ,Drosophila ,Cholinergic neuron ,Neuroscience ,medicine.drug - Abstract
Studies of the familial Parkinson disease-related proteins PINK1 and Parkin have demonstrated that these factors promote the fragmentation and turnover of mitochondria following treatment of cultured cells with mitochondrial depolarizing agents. Whether PINK1 or Parkin influence mitochondrial quality control under normal physiological conditions in dopaminergic neurons, a principal cell type that degenerates in Parkinson disease, remains unclear. To address this matter, we developed a method to purify and characterize neural subtypes of interest from the adult Drosophila brain. Using this method, we find that dopaminergic neurons from Drosophila parkin mutants accumulate enlarged, depolarized mitochondria, and that genetic perturbations that promote mitochondrial fragmentation and turnover rescue the mitochondrial depolarization and neurodegenerative phenotypes of parkin mutants. In contrast, cholinergic neurons from parkin mutants accumulate enlarged depolarized mitochondria to a lesser extent than dopaminergic neurons, suggesting that a higher rate of mitochondrial damage, or a deficiency in alternative mechanisms to repair or eliminate damaged mitochondria explains the selective vulnerability of dopaminergic neurons in Parkinson disease. Our study validates key tenets of the model that PINK1 and Parkin promote the fragmentation and turnover of depolarized mitochondria in dopaminergic neurons. Moreover, our neural purification method provides a foundation to further explore the pathogenesis of Parkinson disease, and to address other neurobiological questions requiring the analysis of defined neural cell types.
- Published
- 2012
41. Culling sick mitochondria from the herd
- Author
-
Leo J. Pallanck
- Subjects
Dynamins ,Carbonyl Cyanide m-Chlorophenyl Hydrazone ,Proteasome Endopeptidase Complex ,ATPase ,Ubiquitin-Protein Ligases ,Reviews ,PINK1 ,Mitochondrion ,Endoplasmic-reticulum-associated protein degradation ,Carbonyl cyanide m-chlorophenyl hydrazone ,Endoplasmic Reticulum ,Membrane Fusion ,Mitochondrial Membrane Transport Proteins ,Models, Biological ,Parkin ,GTP Phosphohydrolases ,Mitochondrial Proteins ,Mitochondrial membrane transport protein ,chemistry.chemical_compound ,Mice ,Autophagy ,Animals ,Humans ,Adenosine Triphosphatases ,biology ,Comment ,Ubiquitination ,Membrane Proteins ,Membrane Transport Proteins ,Nuclear Proteins ,Cell Biology ,Cell biology ,Mitochondria ,Biochemistry ,chemistry ,biology.protein ,Microtubule-Associated Proteins ,Protein Kinases - Abstract
The PINK1–Parkin pathway plays a critical role in mitochondrial quality control by selectively targeting damaged mitochondria for autophagy. In this issue, Tanaka et al. (2010. J. Cell Biol. doi: 10.1083/jcb.201007013) demonstrate that the AAA-type ATPase p97 acts downstream of PINK1 and Parkin to segregate fusion-incompetent mitochondria for turnover. p97 acts by targeting the mitochondrial fusion-promoting factor mitofusin for degradation through an endoplasmic reticulum–associated degradation (ERAD)-like mechanism.
- Published
- 2010
42. Mitochondrial dysfunction in NnaD mutant flies and Purkinje cell degeneration mice reveals a role for Nna proteins in neuronal bioenergetics
- Author
-
Parsa Kazemi-Esfarjani, Soyoung Ryu, David R. Goodlett, Anne N. Murphy, Thomas Toneff, Leo J. Pallanck, Lisa Chakrabarti, Jeremiah Eng, Janice W. Kansy, Rabaab Zahra, Bryce L. Sopher, Albert R. La Spada, Stephen M. Jackson, Michael J. MacCoss, Craig L. Bennett, Amanda G. Mason, Vivian Hook, Gennifer E. Merrihew, and Scott A. Shaffer
- Subjects
Retinal degeneration ,Male ,Proteomics ,Cerebellum ,Mitochondrial Diseases ,Purkinje cell ,HUMDISEASE ,Mitochondrion ,Animals, Genetically Modified ,Mice ,Purkinje Cells ,0302 clinical medicine ,Transduction, Genetic ,Drosophila Proteins ,Cell Line, Transformed ,0303 health sciences ,General Neuroscience ,Neurodegeneration ,Retinal Degeneration ,Serine-Type D-Ala-D-Ala Carboxypeptidase ,3. Good health ,Cell biology ,Mitochondria ,medicine.anatomical_structure ,Phenotype ,Drosophila ,animal structures ,Neuroscience(all) ,Green Fluorescent Proteins ,Oxidative phosphorylation ,Biology ,Transfection ,MOLNEURO ,Retina ,Article ,03 medical and health sciences ,Microscopy, Electron, Transmission ,GTP-Binding Proteins ,medicine ,otorhinolaryngologic diseases ,Animals ,Humans ,Loss function ,030304 developmental biology ,medicine.disease ,Molecular biology ,Disease Models, Animal ,Gene Expression Regulation ,Mutation ,Nerve Degeneration ,CELLBIO ,Energy Metabolism ,030217 neurology & neurosurgery - Abstract
The Purkinje cell degeneration (pcd) mouse is a recessive model of neurodegeneration, involving cerebellum and retina. Purkinje cell death in pcd is dramatic, as >99% of Purkinje neurons are lost in three weeks. Loss-of-function of Nna1 causes pcd, and Nna1 is a highly conserved zinc carboxypeptidase. To determine the basis of pcd, we implemented a two-pronged approach, combining characterization of loss-of-function phenotypes of the Drosophila Nna1 orthologue (NnaD) with proteomics analysis of pcd mice. Reduced NnaD function yielded larval lethality, with survivors displaying phenotypes that mirror disease in pcd. Quantitative proteomics revealed expression alterations for glycolytic and oxidative phosphorylation enzymes. Nna proteins localize to mitochondria, loss of NnaD / Nna1 produces mitochondrial abnormalities, and pcd mice display altered proteolytic processing of Nna1 interacting proteins. Our studies indicate that Nna1 loss-of-function results in altered bioenergetics and mitochondrial dysfunction, and suggest that pcd shares pathogenic features with neurodegenerative disorders such as Parkinson's disease.
- Published
- 2010
43. The mitochondrial fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathway
- Author
-
Angela C. Poole, Evelyn S. Vincow, Leo J. Pallanck, Selina Yu, and Ruth E. Thomas
- Subjects
Ubiquitin-Protein Ligases ,lcsh:Medicine ,PINK1 ,Mitochondrion ,Protein Serine-Threonine Kinases ,medicine.disease_cause ,Parkin ,03 medical and health sciences ,0302 clinical medicine ,Ubiquitin ,medicine ,Drosophila Proteins ,Immunoprecipitation ,lcsh:Science ,Genetics and Genomics/Genetics of Disease ,Neurological Disorders/Movement Disorders ,030304 developmental biology ,Genetics ,Genetics and Genomics/Medical Genetics ,0303 health sciences ,Mutation ,Multidisciplinary ,biology ,Protein Stability ,lcsh:R ,Ubiquitination ,Membrane Proteins ,biology.organism_classification ,nervous system diseases ,Mitochondria ,Genetics and Genomics/Gene Function ,Cytosol ,mitochondrial fusion ,Genetics and Genomics/Disease Models ,Neurological Disorders/Neurogenetics ,biology.protein ,lcsh:Q ,Drosophila melanogaster ,Neuroscience/Neurobiology of Disease and Regeneration ,030217 neurology & neurosurgery ,Research Article - Abstract
Loss-of-function mutations in the PINK1 or parkin genes result in recessive heritable forms of parkinsonism. Genetic studies of Drosophila orthologs of PINK1 and parkin indicate that PINK1, a mitochondrially targeted serine/threonine kinase, acts upstream of Parkin, a cytosolic ubiquitin-protein ligase, to promote mitochondrial fragmentation, although the molecular mechanisms by which the PINK1/Parkin pathway promotes mitochondrial fragmentation are unknown. We tested the hypothesis that PINK1 and Parkin promote mitochondrial fragmentation by targeting core components of the mitochondrial morphogenesis machinery for ubiquitination. We report that the steady-state abundance of the mitochondrial fusion-promoting factor Mitofusin (dMfn) is inversely correlated with the activity of PINK1 and Parkin in Drosophila. We further report that dMfn is ubiquitinated in a PINK1- and Parkin-dependent fashion and that dMfn co-immunoprecipitates with Parkin. By contrast, perturbations of PINK1 or Parkin did not influence the steady-state abundance of the mitochondrial fission-promoting factor Drp1 or the mitochondrial fusion-promoting factor Opa1, or the subcellular distribution of Drp1. Our findings suggest that dMfn is a direct substrate of the PINK1/Parkin pathway and that the mitochondrial morphological alterations and tissue degeneration phenotypes that derive from mutations in PINK1 and parkin result at least in part from reduced ubiquitin-mediated turnover of dMfn.
- Published
- 2009
44. The PINK1/Parkin pathway: a mitochondrial quality control system?
- Author
-
Leo J. Pallanck and Alexander J. Whitworth
- Subjects
Genetics ,Physiology ,Ubiquitin-Protein Ligases ,Neurodegeneration ,PINK1 ,Parkinson Disease ,Cell Biology ,Biology ,Mitochondrion ,medicine.disease ,Human mitochondrial genetics ,Parkin ,nervous system diseases ,Cell biology ,Mitochondria ,mitochondrial fusion ,Mitophagy ,medicine ,Autophagy ,Animals ,Humans ,Mitochondrial fission ,Protein Kinases - Abstract
Significant insight into the mechanisms that contribute to dopaminergic neurodegeneration in Parkinson disease has been gained from the analysis of genes linked to rare heritable forms of parkinsonism such as PINK1 and parkin, loss-of-function mutations of which cause autosomal recessive parkinsonism. PINK1 encodes a mitochondrially targeted Ser/Thr kinase and parkin encodes a ubiquitin-protein ligase. Functional studies of PINK1 and Parkin in animal and cellular model systems have shown that both proteins play important roles in maintaining mitochondrial integrity. Genetic studies of PINK1 and Parkin orthologs in flies have shown that PINK1 acts upstream from Parkin in a common pathway that appears to regulate mitochondrial morphology. Mitochondrial morphology is regulated by mitochondrial fission and fusion-promoting proteins, and is important in a variety of contexts, including mitochondrial trafficking and mitochondrial quality control. In particular, mitochondrial fission appears to promote the segregation of terminally dysfunctional mitochondria for degradation in the lysosome through a process termed mitophagy. Recent work has shown that Parkin promotes the degradation of dysfunctional mitochondria in vertebrate cell culture. Here we postulate a model whereby the PINK1/Parkin pathway regulates mitochondrial dynamics in an effort to promote the turnover of damaged mitochondria.
- Published
- 2009
45. Genetic models of Parkinson's disease: mechanisms and therapies
- Author
-
Alexander J, Whitworth and Leo J, Pallanck
- Subjects
Animals, Genetically Modified ,Disease Models, Animal ,Drosophila melanogaster ,Models, Animal ,Nerve Degeneration ,alpha-Synuclein ,Animals ,Drosophila Proteins ,Humans ,Parkinson Disease - Published
- 2008
46. The PINK1/Parkin pathway regulates mitochondrial morphology
- Author
-
Leo J. Pallanck, Ruth E. Thomas, Laurie A. Andrews, Alexander J. Whitworth, Heidi M. McBride, and Angela C. Poole
- Subjects
Ubiquitin-Protein Ligases ,Mutant ,MFN2 ,Gene Dosage ,PINK1 ,Mitochondrion ,Biology ,medicine.disease_cause ,Eye ,Membrane Fusion ,Parkin ,GTP-Binding Proteins ,medicine ,Animals ,Drosophila Proteins ,Humans ,Genetics ,Mutation ,Multidisciplinary ,Membrane Proteins ,Parkinson Disease ,Biological Sciences ,nervous system diseases ,Mitochondria ,Cytoskeletal Proteins ,mitochondrial fusion ,Mitochondrial fission ,Drosophila ,Mitochondrial Swelling ,Protein Kinases - Abstract
Loss-of-function mutations in the PTEN-induced kinase 1 ( PINK1 ) or parkin genes, which encode a mitochondrially localized serine/threonine kinase and a ubiquitin-protein ligase, respectively, result in recessive familial forms of Parkinsonism. Genetic studies in Drosophila indicate that PINK1 acts upstream of Parkin in a common pathway that influences mitochondrial integrity in a subset of tissues, including flight muscle and dopaminergic neurons. The mechanism by which PINK1 and Parkin influence mitochondrial integrity is currently unknown, although mutations in the PINK1 and parkin genes result in enlarged or swollen mitochondria, suggesting a possible regulatory role for the PINK1/Parkin pathway in mitochondrial morphology. To address this hypothesis, we examined the influence of genetic alterations affecting the machinery that governs mitochondrial morphology on the PINK1 and parkin mutant phenotypes. We report that heterozygous loss-of-function mutations of drp1 , which encodes a key mitochondrial fission-promoting component, are largely lethal in a PINK1 or parkin mutant background. Conversely, the flight muscle degeneration and mitochondrial morphological alterations that result from mutations in PINK1 and parkin are strongly suppressed by increased drp1 gene dosage and by heterozygous loss-of-function mutations affecting the mitochondrial fusion-promoting factors OPA1 and Mfn2. Finally, we find that an eye phenotype associated with increased PINK1/Parkin pathway activity is suppressed by perturbations that reduce mitochondrial fission and enhanced by perturbations that reduce mitochondrial fusion. Our studies suggest that the PINK1/Parkin pathway promotes mitochondrial fission and that the loss of mitochondrial and tissue integrity in PINK1 and parkin mutants derives from reduced mitochondrial fission.
- Published
- 2008
47. Ataxin-2 and its Drosophila homolog, ATX2, physically assemble with polyribosomes
- Author
-
Terrence F. Satterfield and Leo J. Pallanck
- Subjects
Nerve Tissue Proteins ,Biology ,Models, Biological ,Poly(A)-Binding Proteins ,Protein structure ,Polysome ,Translational regulation ,Genetics ,medicine ,Protein biosynthesis ,Animals ,Drosophila Proteins ,Humans ,RNA, Messenger ,Molecular Biology ,Genetics (clinical) ,Cells, Cultured ,Ataxin-2 ,Neurodegeneration ,RNA-Binding Proteins ,Neurodegenerative Diseases ,General Medicine ,Anatomy ,Polyglutamine tract ,medicine.disease ,Cell biology ,Protein Structure, Tertiary ,Ataxins ,Ataxin ,Polyribosomes ,Protein Biosynthesis ,Spinocerebellar ataxia ,Drosophila ,Peptides - Abstract
Mutations resulting in the expansion of a polyglutamine tract in the protein ataxin-2 give rise to the neurodegenerative disorders spinocerebellar ataxia type 2 and Parkinson's disease. The normal cellular function of ataxin-2 and the mechanism by which polyglutamine expansion of ataxin-2 causes neurodegeneration are unknown. Here, we demonstrate that ataxin-2 and its Drosophila homolog, ATX2, assemble with polyribosomes and poly(A)-binding protein (PABP), a key regulator of mRNA translation. The assembly of ATX2 with polyribosomes is mediated independently by two distinct evolutionarily conserved regions of ATX2: an N-terminal Lsm/Lsm-associated domain (LsmAD), found in proteins that function in nuclear RNA processing and mRNA decay, and a PAM2 motif, found in proteins that interact physically with PABP. We further show that the PAM2 motif mediates a physical interaction of ATX2 with PABP in addition to promoting ATX2 assembly with polyribosomes. Our results suggest a model in which ATX2 binds mRNA directly through its Lsm/LsmAD domain and indirectly via binding PABP that is itself directly bound to mRNA. These findings, coupled with work on other ataxin-2 family members, suggest that ATX2 plays a direct role in translational regulation. Our results raise the possibility that polyglutamine expansions within ataxin-2 cause neurodegeneration by interfering with the translational regulation of particular mRNAs.
- Published
- 2006
48. Drosophila models pioneer a new approach to drug discovery for Parkinson's disease
- Author
-
Alexander J. Whitworth, Paul D. Wes, and Leo J. Pallanck
- Subjects
Pathology ,medicine.medical_specialty ,Parkinson's disease ,Ubiquitin-Protein Ligases ,Nerve Tissue Proteins ,Computational biology ,Disease ,Parkin ,chemistry.chemical_compound ,Drug Discovery ,Genetic model ,medicine ,Animals ,Drosophila Proteins ,Humans ,Drosophila ,Pharmacology ,Alpha-synuclein ,biology ,Drug discovery ,Parkinson Disease ,biology.organism_classification ,medicine.disease ,Disease Models, Animal ,Drosophila melanogaster ,chemistry ,Drug Design ,alpha-Synuclein - Abstract
Despite the prevalence and severity of Parkinson's disease (PD), little is known about the molecular etiology of this disease, and preventative and disease-modifying therapies remain elusive. Recently, linkage studies have begun to identify single-gene mutations that are responsible for rare, heritable forms of PD, which offer an opportunity to gain insight into the molecular mechanisms of this disorder through the creation and analysis of appropriate animal models. One model system that is tractable for these studies is the fruit fly, Drosophila melanogaster. Analysis of several Drosophila models of PD has revealed some surprising insights into the pathogenesis of PD and begun to highlight potential treatment strategies.
- Published
- 2006
49. Mutations of a Drosophila NPC1 gene confer sterol and ecdysone metabolic defects
- Author
-
Tracey J. Parker, Leo J. Pallanck, and Megan L. Fluegel
- Subjects
Male ,Protein family ,Mutant ,Genes, Recessive ,Investigations ,medicine.disease_cause ,Animals, Genetically Modified ,Cholesterol, Dietary ,chemistry.chemical_compound ,Niemann-Pick C1 Protein ,Genetics ,medicine ,Animals ,Drosophila Proteins ,Gene ,Niemann-Pick Diseases ,Mutation ,biology ,fungi ,Gene Expression Regulation, Developmental ,Membrane Proteins ,biology.organism_classification ,Null allele ,Neurosecretory Systems ,Sterols ,Drosophila melanogaster ,Ecdysterone ,chemistry ,Larva ,Female ,Genes, Lethal ,Drosophila Protein ,Ecdysone - Abstract
The molecular mechanisms by which dietary cholesterol is trafficked within cells are poorly understood. Previous work indicates that the NPC1 family of proteins plays an important role in this process, although the precise functions performed by this protein family remain elusive. We have taken a genetic approach to further explore the NPC1 family in the fruit fly Drosophila melanogaster. The Drosophila genome encodes two NPC1 homologs, designated NPC1a and NPC1b, that exhibit 42% and 35% identity to the human NPC1 protein, respectively. Here we describe the results of mutational analysis of the NPC1a gene. The NPC1a gene is ubiquitously expressed, and a null allele of NPC1a confers early larval lethality. The recessive lethal phenotype of NPC1a mutants can be partially rescued on a diet of high cholesterol or one that includes the insect steroid hormone 20-hydroxyecdysone. We also find that expression of NPC1a in the ring gland is sufficient to rescue the lethality associated with the loss of NPC1a and that cholesterol levels in NPC1a mutant larvae are unchanged relative to controls. Our results suggest that NPC1a promotes efficient intracellular trafficking of sterols in many Drosophila tissues including the ring gland where sterols must be delivered to sites of ecdysone synthesis.
- Published
- 2005
50. Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease
- Author
-
Leo J. Pallanck, Dorothy A. Theodore, Paul D. Wes, Jessica C. Greene, Helen Beneš, and Alexander J. Whitworth
- Subjects
Parkinson's disease ,Ubiquitin-Protein Ligases ,Green Fluorescent Proteins ,Gene Expression ,Biology ,medicine.disease_cause ,Parkin ,Interneurons ,medicine ,Animals ,Drosophila Proteins ,Glutathione Transferase ,Genetics ,Mutation ,Multidisciplinary ,Microscopy, Confocal ,Parkinsonism ,Neurodegeneration ,Dopaminergic ,Parkinson Disease ,Biological Sciences ,medicine.disease ,nervous system diseases ,Nerve Degeneration ,Drosophila ,Drosophila Protein ,Locomotion ,Genetic screen - Abstract
Loss-of-function mutations of the parkin gene are a major cause of early-onset parkinsonism. To explore the mechanism by which loss of parkin function results in neurodegeneration, we are using a genetic approach in Drosophila . Here, we show that Drosophila parkin mutants display degeneration of a subset of dopaminergic (DA) neurons in the brain. The neurodegenerative phenotype of parkin mutants is enhanced by loss-of-function mutations of the glutathione S-transferase S1 ( GstS1 ) gene, which were identified in an unbiased genetic screen for genes that modify parkin phenotypes. Furthermore, overexpression of GstS1 in DA neurons suppresses neurodegeneration in parkin mutants. Given the previous evidence for altered glutathione metabolism and oxidative stress in sporadic Parkinson's disease (PD), these data suggest that the mechanism of DA neuron loss in Drosophila parkin mutants is similar to the mechanisms underlying sporadic PD. Moreover, these findings identify a potential therapeutic approach in treating PD.
- Published
- 2005
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.